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ABSTRACT 
 
Part 1: Progress Toward the Total Synthesis of Platensimycin 
Part 2: Aromatic Ions: Carbon–Based Nucleofuges and Chiral Cyclopropenones 
and Formamides  
 
Ethan Lawrence Fisher 
 
 This thesis describes progress toward to the total synthesis of the natural product 
platensimycin, the development of proficient carbon nucleofuges for the Tsuji–Trost 
allylation, and the use of chiral cyclopropenones and formamides for the kinetic 
resolution of alcohols by chlorodehydration.   
 The first chapter describes efforts in the total synthesis of platensimycin.  The 
synthesis attempted to use a thermal rearrangement, through a biradical intermediate, and 
then radical induced [3+2] cycloaddition between a vinyl cyclopropane and pendant 
olefin to create the core of platensimycin.  A revised strategy was employed using a 
palladium(0) catalyzed Heck cascade and palladium(II) catalyzed alkoxypalladation. 
 The second chapter describes the development of a carbon-based nucleofuge.  A 
substituted cyclopentadienyl anion served as a competent leaving group in the Tsuji–
Trost allylation.  Various substrates were examined including carbon and nitrogen 
nucleophiles.  The reaction mechanism with nitrogen nucleophiles is studied.     
 The third chapter describes the synthesis of chiral cyclopropenones and their use 
in the kinetic resolution of alcohols by chlorodehydration.  Chiral formamides are also 
studied for their use in chlorodehydration.  Transition states for enantiodifferentiation are 
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Progress Toward the Total Synthesis of Platensimycin 
 
 The development of antibiotics and antibacterials for the treatment of bacterial 
infections was one of the defining features of the 20th century.  These drugs, synthesized 
from plant matter or in the laboratory, have saved countless human lives.  In addition, 
chemists have used antibiotics as a platform for the development of new chemical 
methods.  This introduction will briefly cover three antibiotics and new chemical tools 
that were necessary for their total synthesis.  
 Prior to the production of synthetic drugs, plants served as a natural source for the 
treatment of ailments.  Three of these common drugs still used today are salicylic acid, 
morphine, and quinine (Figure 1).  These natural products have been extensively studied 
and modified to increase effectiveness and safety.1  For example, acetylation of the 
hydroxyl group of salicylic acid, acetylsalicylic acid, lessens the risk of digestive 
problems. Morphine, a highly addictive painkiller, can be O-methylated to produce 
codeine, a less potent analgesic that has a lower risk of chemical dependence.  The 
antimalarial drug quinine has been derivitized as the thiosulfuric acid, which results in 







Figure 1. Natural products and their derivatives 
 
 
 Antibiotic development began in the early 1940s with the discovery of the β-
lactams (i.e., penicillins, cephalosporins, carbapenams) and proliferated until the mid 
1970s.3  This period, referred to as the “Golden Age,” saw a tremendous increase in 
efforts from the government, academia, and pharmaceutical companies to develop new 
antibiotics.  The pressures of World War II led to an increased study of antibiotics and 
their syntheses.  During those 30 years, the scientific community produced drugs such as 
tetracycline, erythromycin, and vancomycin, common drugs still used today.  The 1970s 
marked a decrease in antibiotic development with the steep downgrade of production and 
funding.   
 Bacterial resistance to antibiotics has become a grave concern with the 
appearance of vancomycin-resistant Staphylococcus aureus and Enterococcus faecalis.4  






































effective against the resistant strains.  To the chemical community, new structures pose a 
challenge in development of efficient syntheses.  Three structures that will be discussed 
in this chapter are penicillin, erythronolide B, and platensimycin.  These compounds have 




 After the reports by Fleming5 and Chain and Florey6 regarding the initial 
discovery and biological properties of penicillin G, chemists in both the United States and 
Britain began disclosing their findings of the structure and syntheses. In the early part of 
the 1940s, a vast number of reports surfaced regarding the syntheses of penicillin G, all 
with conflicting biological data.7  The originally proposed oxazolone-thiazolidine 
structure was accepted by most laboratories (Figure 2).  The strategy most commonly 
used was to condense an oxazolone containing a potential aldehyde group (here as an 
enol ether) and d-penicillamine.  The proposed structure was synthesized, but biological 
activity ranged from 0.5 to 275 units/mg in vitro activity.  This discrepancy in activity led 
researchers to believe that penicillin G was indeed being formed by the condensation, but 







Figure 2. Proposed synthesis of penicillin G 
 
  
 The first synthetically–produced penicillin G was made by the condensation of 2-
benzyl-4-methoxymethylidene-5(4H)-oxazolone and d-penicillamine with Et3N in 
pyridine giving a biologically inert intermediate (Figure 3).  Heating this compound with 
pyridinium chloride furnished the correct, biologically active structure.  This report was a 
boost to the synthetic community, showing that synthetically derived antibiotics could be 
used instead of naturally occurring sources. 
 

































+ 1. Et3N, Pyr
2. pyridinium












 The novel β-lactam unit sparked interest in developing methods to create the 
highly strained and reactive functionality.  β-Lactams are sensitive to both acidic and 
basic media, which cause cleavage of the amide bond.  A mild and efficient synthetic 
method was required if analogs were to be studied.   
 A related molecule, penicillin V, was the focus of research by Sheehan.  In 1955, 
Sheehan reported that dicyclohexylcarbodiimide (DCC) was capable of forming amide 
bonds from amines and carboxylic acids in water.8  This reaction was pH neutral and as 
such, attractive for the formation of β-lactams.  Thus, treatment of an amino acid with 
KOH then DCC afforded (+)-penicillin V potassium salt in 10-12% yield (Figure 4).9  
Since this publication, DCC has become an indispensible reagent for condensation 
reactions. 
 














1. KOH (1 eqiv)
2. DCC (4 eqiv)
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(+)-penicillin V potassium salt




 The abundance of stereocenters about the 14-membered lactone made the 
synthesis of erythronolide B a formidable task.  No efficient method at that time had been 
created to close a 14-membered lactone (Figure 5).   In identifying a solution to this 
problem, chemists must determine what substrate would be capable of such a 
transformation (i.e., protecting groups, conformational analysis) and what reagents would 
be proficient. 
Figure 5. Erythronolide B 
 
  
 In Corey’s synthesis of erythronolide B, a new method for macrolactonization 
was exemplified.10  A protected hydroxy acid was treated with a substituted diimidazole 
disulfide and triphenylphosphine to form an intermediate thioester (Figure 6).  Heating in 
toluene effected the transesterification generating the lactone in 50% yield.  The necessity 
for a transformation, initiated by a synthetic desire, resulted in the Corey–Nicolaou 

































Figure 6. Corey–Nicolaou macrolactonization 
  
Platensimycin   The last natural product that this chapter will discuss is platensimycin.  In 2006, 
researchers at Merck reported the isolation of the potent antibiotic platensimycin 1 from 
Streptomyces platensis (Figure 7).11  This structure is only the third new antibiotic class to 
be discovered in the past 40 years and shows promise as a therapeutic lead.  
Platensimycin inhibits fatty acid biosynthesis targeting β-ketoacyl-ACP (acyl carrier 
protein) synthase (FABF), and exhibits an IC50 = 0.1 µL⋅mL-1 against S. aureus.  It is also 
active against vancomycin-resistant enterococci and linezolid– and macrolide–resistant 
pathogens.  Targeting of fatty acid biosynthesis is a novel pathway for antibiotics, 
meaning that the potential for immediate drug resistance is low.  Platensimycin shows no 
inhibition of DNA, RNA, protein, or cell wall biosynthesis at 500 mg⋅mL-1.  The potent 
activity, compact complex structure, and promise as a new antibiotic sparked our, and 
other groups’,12 interest in development of a total synthesis.  Over the past five years, 









































    50%
8  
 
Figure 7. Platensimycin 
 
  
 The biosynthesis of platensimycin was studied by the isolation chemists at 
Merck.13  Through 13C precursor incorporation experiments, they determined that the C-
17 tetracyclic platensic acid was consistent with a non–mevalonate terpenoid pathway.  
The terpenoid pathway begins with coupling of isomeric isopentenyl diphosphate and 
dimethylallyl diphosphate to form geranylgeranyl diphosphate (GGDP) (Figure 8).  This 
diterpenoid precursor is cyclized to an intermediate ent–kaurane or an isomeric tricyclic 
compound.  Oxidation at C-1 shortens the diterpenoid and creates the carboxylic acid 
group, which also is oxidized at C-5 to reveal the ketone functionality, and between C-10 
and C-15 to form the bridged tricycle.  The aniline unit is most likely synthesized 







! Produced by Streptomyces platensis
! Inhibits fatty acid biosynthesis by
binding to Cys163 of FabF inhibiting
Malonyl-ACP binding
! Active against methicillin-resistant S.
aureus, vancomycin-resistant














Figure 8. Biosynthetic pathway to platensic acid 
 
 
 Beyond the need for developing rapid and efficient syntheses of potential 
antibiotics and analogs, the unique tetracyclic caged structure is what I believe fueled the 
many efforts.  New architectures can revitalize inspiration in total synthesis and each of 
the published syntheses is unique, using non-obvious bond disconnections or quickly 
creating highly functionalized carbon centers.   A brief summary of the key features in 
three of these syntheses will be described.   
 Only four months after the publication of the structure of platensimycin, the 
Nicolaou group reported the first racemic total synthesis.12a  In four steps from 3-ethoxy-
2-cyclohexenone an enyne was prepared for a ruthenium catalyzed cycloisomerization 
(Figure 9).  A subsequent Saegusa oxidation followed by silyl enol ether cleavage 
afforded a dieneonecarboxaldehyde.  The key step in this synthesis was a SmI2 induced 
ketyl radical cyclization to form a 2:1 mixture of diastereomeric alcohols.  The desired 






































This reaction was made enantioselective by using a chiral rhodium catalyst 
([{Rh(cod)Cl}2]/ (S)-BINAP) with a modified substrate in the cycloisomerization step.  
 
Figure 9. Nicolaou’s synthesis of platensimycin 
 
 
 Shortly after Nicolaou’s report, the Snider group published their formal synthesis 
of the tetracyclic core.12e In their synthesis, 5-methoxy-1-tetralone underwent a reductive 
alkylation to yield a substituted bicyclic compound as a mixture of epimerizable 
diastereomers (Figure 10).  Treatment of the vinyl bromide with n-Bu3SnH and AIBN 
effected a conjugate addition revealing a ketone, which was then reduced with L-
Selectride to generate a diastereomeric mixture of diols.  Addition of trifluoroacetic acid 
induced the etherification, which was similar to the route of Nicolaou.  This final carbon–




















Figure 10. Snider’s synthesis of platensimycin 
 
  
 The previous two examples focused formation of the tricyclic moiety as a late 
stage endeavor.  This method is an obvious choice because a simple precursor to this ring 
system is not evident.  The Yamamoto group saw the cyclohexenone ring as a potential 
place to construct complexity.  They identified the Robinson annulation as a possible 
reaction to construct the ring (Figure 11).12f  Starting with a [2.2.1]-bicyclic compound 
formed by an enantioselective Diels–Alder, a Baeyer–Villiger oxidation afforded the 
lactone, which was rearranged in situ by a dehydrative lactonization to form a [3.3.0]-
bicycle.  Further elaboration to the enone-carboxaldehyde resulted in a structure poised 
for an L-proline catalyzed Robinson annulation to yield the tetracyclic core of 






























Figure 11. Yamamoto’s synthesis of platensimycin 
 
 
 In designing a strategy for the synthesis of platensimycin 1, we saw the primary 
challenge as the synthesis of the caged, tetracyclic core 3 (Figure 12).  Enone 2 could 
arrive from allylic oxidation of tetracyclic compound 3.  In our initial plan we sought to 
construct core 3 via a radical–induced formal [3+2] cycloaddition of vinyl cyclopropane 
4.  This architecture could be constructed by a substrate–directed cyclopropanation 
followed by enol ether installation of bicyclic compound 5, which in turn could arise 
from the ring-closing enyne metathesis of dienyne 6.  We felt that this strategy utilizes 




































Figure 12. Retrosynthetic analysis of platensimycin 
 
 
First Generation Synthesis 
  
 Our synthesis of the enyne metathesis substrate (6) began with the Wittig 
olefination of propionaldehyde and the commercially available phosphonium salt 7 to 
yield 5-octenoic acid 8 as an E/Z mixture (Figure 13).  Ultimately, the stereochemistry 
about the olefin is destroyed in the enyne metathesis and therefore the mixture was taken 
forward without separation.  Acid 8 was protected as the methyl ester and then subjected 
to a boron–mediated aldol addition between the Z-enolate and freshly prepared 3-
butenal14 to furnish syn adduct 10 as a single diastereomer.  Protection of the resulting 
alcohol as the TBS ether followed by a reduction/oxidation protocol revealed aldehyde 
































Figure 13. Preparation of enyne 6 
 
 
 Enyne metathesis is a powerful tool to construct dienes from easily available 
olefins and alkynes.15  A variant of this reaction, ring-closing enyne metathesis, has the 
added advantage of creating mono-, bi-, and possibly polycyclic scaffolds.  In developing 
a substrate for the ring-closing metathesis for the formation of bicycle 13, we needed to 
consider substitution about the olefins and possible implications of the reaction 
mechanism.   
 There are two possible isomeric products, bicycles 13 and 14, which would result 
















































olefin substitution can influence reaction rates, we created a mono- and disubstituted 
olefin system to perturb the system to favor the formation of bicycle 13.16  
 The reaction mechanism can influence the selectivity in the ratio of products.  
There are two possible reaction mechanisms: initial activation of the olefin and initial 
activation of the alkyne.  In the first case, the least hindered olefin is preferred and forms 
metallocycle 15.  Cycloreversion expelling ethylene generates ruthenium carbene 16, 
which quickly cyclizes with the alkyne to form metallocyclobutene 17.  Another 
cycloreversion creates the first cyclopentene ring and a ruthenium carbene capable of ring 
closing metathesis to furnish the desired product and release the catalyst.  Alternatively, 
the alkyne could react first with the ruthenium catalyst to form metallocyclobutene 19, 
which then cycloreverts to form carbene 20.  This intermediate reacts with the least 
hindered olefin by a cycloaddition-reversion sequence to form cyclopentene 22.  At this 












Figure 14. Mechanistic considerations of the enyne metathesis 
 
 
 With the dienyne 6 in hand, we treated it with Grubb’s 1st generation catalyst in 


































! Initial activation of terminal olefin















! Two isomeric products
17  
affirmed our theory that olefin substitution would be adequate to retard the production of 
unwanted isomers.  This result also confirms that the aldol addition of ester 9 and 3-
butenal (refer to Figure 13) resulted in a single diastereomer, because no evidence of the 
diastereomeric silyl ether was apparent. 
 
Figure 15. Ring closing enyne metathesis of enyne 6 
 
  
 Treatment of silyl ether 13 with pyridinium p-toluenesulfonate in methanol 
afforded the free alcohol in excellent yield (Figure 16).  This substrate was sensitive to 
strong acids and bases often resulting in decomposition.  The buffered conditions of 
methanolic pyridinium p-toluenesulfonate proved to be the best conditions for the 
deprotection.  Diene 5 was then subjected to the Furukawa modification17 of the 
Simmons–Smith cyclopropanation.  Under these conditions, Et2Zn and CH2I2, the 
intermediate zinc complex is able to coordinate to the hydroxyl group to deliver the 
methylene unit to the α-face of the bicycle.  Additionally, the proximity of the alcohol to 
the cyclopentene olefin compared to the cyclohexene olefin encourages high 
regioselectivity to form tricycle 23.  Finally, we looked to installation of the enol ether 















anhydride and pyridine (Figure 16). Unfortunately variations of the Tebbe or Petasis 
olefination resulted in trace product with a majority of decomposition.  It is probable that 
the reaction conditions are not suitable to the highly strained and reactive enol ether and 
vinyl cyclopropane functionalities of tricycle 4. We then looked at an alternative method.  
Treatment of alcohol 23 with 2-methoxypropene with catalytic pyridinium p-
toluenesulfonate followed by addition of Et3N and TMSOTf revealed enol ether 4.  This 
final step often proved to be sensitive to moisture and impurities causing variable yields.  
 
Figure 16. Preparation of tricycle 4 
 
 
 Our proposed strategy for the rearrangement of vinyl cyclopropane 4 to 





















! Functionalization of bicycle 13















biradical 4a (Figure 17).  The biradical would then react with the olefin to form the 
cyclopentene ring of tetracycle 3.  Unfortunately heating up to 300 °C resulted in no 
reaction and full recovery of starting material.  Higher temperatures resulted in 
decomposition. 
 
Figure 17. Thermal rearrangement 
 
 
 The unsuccessful rearrangement of tricycle 4 led us to ponder other radical 
processes.   Our attention turned to a stepwise approach.  We relied on a report that 
catalytic phenylthio radical was capable of facilitating a formal [3+2] cycloaddition 
between enol ethers and vinyl cyclopropanes.18  Our mechanistic proposal is described in 
Figure 18.  A radical, PhS⋅, would add to the olefin, causing the cyclopropane to rupture 
and generate radical 25.  A 5-exo-trig cyclization would afford the primary radical 26, 
which would again cyclize to form intermediate 27.  Expulsion of PhS⋅ would regenerate 

















Figure 18. Radical cascade mechanism 
 
 
 We sought then to find appropriate radical conditions for the rearrangement to 
tetracycle 3.  Many stabilized sulfur and tin radical sources were screened, such as Ph2S2 
and (Bu3Sn)2, with initiators, such as AIBN and (PhCO2)2, under both photochemical and 
thermal conditions (Table 1).  Unfortunately, the substrate was resistant to most radical 

















X, Y = OR, CO2Et
Ph2S2, AIBN
PhH, h!, heat X
Y
! Intermolecular [3+2] cyclization







benzene did a reaction occur.  In less that 1 hr, the starting material was fully consumed, 
but no desired product was formed.   
 
Table 1. Radical Conditions 
 
 
 By 1H NMR analysis, it is evident that the thiolacetic radical did add to the olefin 
and rupture the cyclopropane.  We suspect that the geometry of the enol ether precluded 
the correct cyclization to occur in its entirety (Figure 19).  Addition of the thio radical 
would result in intermediate 25, which may be in equilibrium with its isomer 25a.  
Cyclization would result in primary radical 28, which is unable to undergo further 
cyclization and structures such as 29 are possibly obtained.   In addition, given the fact 
































































Figure 19. Radical cyclization of tricycle 4 
 
 
Second Generation Synthesis 
 
 The irreversibility of the radical sequence in the first synthetic route prompted us 
to consider an alternative, though related, strategy to form the platensimycin core.  
Treatment of a structure such as 30 with a radical would ideally fragment the vinyl 
cyclopropane in a similar fashion to tricycle 4 and yield radical 31 (Figure 20).  The 
resulting radical is both tertiary and stabilized by the adjacent oxygen.  We suggest this 
stabilized radical could attack the terminal olefin in the endo conformation to result in 
primary radical 33.  Final cyclization and regeneration of the thio radical would afford 
core 3.  If, however, structure 32 is formed, resulting from an exo cyclization, the 
instability of the generated primary radical and inability to cyclize should cause the 
























Figure 20. Reversible radical cyclization 
 
 
 To synthesize vinyl cyclopropane 30, we did not think that cyclopropanation, 
similar to the method used in Figure 16, would be amenable to our system.  The precursor 
would not have a free alcohol to aid in differentiation of olefins.  We were intrigued by a 
report from Grigg19 in which alkylpalladium species unable to β-hydride eliminate are 
capable of forming highly strained cyclopropane systems (Figure 21).  In fact, this report 
showed a synthesis that maps on quite well to the architecture of tricycle 30.  A vinyl 
triflate (34) with an appended 1,1-disubstituted olefin under the influence of palladium(0) 
can effect an intramolecular Heck cyclization to yield neopentylpalladium intermediate 
35 unable to  β-hydride eliminate.  The alkylpalladium inserts into the olefin forming a 
cyclopropane and then eliminates to furnish vinyl cyclopropane 36 in high yield.  This 



























Figure 21. Cascade Heck Cyclization 
 
 
 The synthesis of tricycle 30 could arise by utilizing a palladium–catalyzed Heck 
cascade of vinyl bromide 37 (Figure 22).  Insertion of palladium followed by olefin 
insertion would produce intermediate 39, which is incapable of β-hydride elimination.  A 
second olefin insertion forms cyclopropane 40, which then reductively eliminates 

































Figure 22. Heck cascade to tricycle 30 
 
 
 The synthesis began from the known transformation of 2-bromocyclohexenone to 
alcohol 43 (Figure 23).20  Thus, Luche reduction of ketone 41 followed by propargylation 
and protection of the terminal alkyne with TMSCl yielded propargyl ether 42.  Addition 
of n-BuLi at low temperature effected the [2,3]-Wittig rearrangement to furnish alcohol 
43 as a single diastereomer.  With two stereocenters in place, the TMS group was 
removed with basic methanol and the alkyne was reduced with H2 and Lindlar catalyst to 
give olefin 44.  Hydroboration-oxidation of the allylic alcohol yielded 1,3-diol 45 in good 







































hydroboration.  Protection of the hydroxyl group with various groups (TMS, TBS), 
reduced the yield of the vicinal diol, but required two additional steps for installation and 
removal. 
 
Figure 23. Preparation of diol 45 
 
 
 Diol 45 was then monoprotected as TIPS ether 46 and acetylated to yield acetate 
47 (Figure 24).  Attempts to transform the acetate into an isopropene with the Tebbe or 
Petasis reagents were unsuccessful.  Alternative methods, such as 2-methoxypropene 
with PPTS (which was used in the first generation synthesis) or with catalytic Hg(OAc)221 
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Figure 24. Attempts at the synthesis of Heck substrate 39 
 
 
 This route, however, was not a complete loss.  Upon inspection of alkylpalladium 
intermediate 39 (Figure 22), it was quickly noted that in addition to a Heck reaction, 
intermediate 39 could arise from a palladium(II)–facilitated alkoxypalladation (Figure 
25).  Utilization of a starting material such as diene 48 would obviate the need to create 
elusive enol ether 37.  In addition, we looked at shortening the synthesis (nine steps to 






































! Preparation of Heck substrate
! Alternative enol ether installation
28  
 
Figure 25. Alkoxypalladation route to intermediate 39 
 
 
 This revised synthesis again began with vinyl bromide 43 (Figure 26).  
Hydroboration-oxidation of the silyl alkyne results in carboxylic acid 49.  The prior route 
would have utilized a number of reductions and oxidations to arrive at the final terminal 
olefin side chain in structure 30.  This revised route relies only on late stage manipulation 
to the desired oxidation state.  The acid was converted to Weinreb amide 50 and then 
coupled with potassium isopropenyltrifluoroborate to furnish diene 51.  Finally we were 
poised to attempt a cyclization to tricycle 52. 
 




















































 Alkoxypalladation of a diene could potentially have multiple products arising 
from attack of the alcohol at one of four olefinic carbons.  According to Baldwin’s rules, 
a 5-exo trig cyclization should be preferred over a 6-endo trig cyclization.   Additionally, 
the competition between a 5- and 4-exo trig cyclization should encourage five-membered 
ring formation.  Under optimized conditions of catalytic Pd(OAc)2, stoichiometric 
Cu(OAc)2 as oxidant, and anhydrous Na2HPO4 in DMSO at 65 °C, the starting material 
was fully consumed to form a new product (Figure 27).  At this point, the desired tricycle 
was not formed.  Rather, an initial 6-endo trig cyclization occurred, yielding a stable π-
allyl palladium intermediate (53) that β-hydride eliminated to deliver bicycle 54.  We 
initially felt that steric effects might preclude π-allyl palladium formation, which turned 
out not to be the case. 
 
Figure 27. Cyclization of diene 51 
 
 
 In order to get the alcohol to add to the correct carbon, we needed to exploit a 































form a π-allyl palladium intermediate, so nucleophiles add to the terminus.22  Reversal of 
this process (adding the nucleophile to the internal position) would require development 
of a significant positive charge at the desired carbon.  Such is the case in 
alkxoymercuration.  If diene 51 were treated with electrophilic mercury(II), cationic 
charge would accumulate at the desired carbon because it is both tertiary and allylic.  
Luckily, the addition of Hg(OAc)2 to the diene in MeCN at –20 °C and then adding 
saturated aqueous NaCl afforded the desired tetrahydrofuran (55) as a 3:1 mixture of 
separable diastereomers (Figure 28).  The connectivity of this structure was verified by 
COSY, HSQC, HMBC and NOESY spectroscopy. 
 
Figure 28. Alkoxymercuration of diene 51 
 
 
 With one bond formed, the next task was to form the cyclopropane.  Any attempts 
to transmetallate the mercurial chloride onto palladium or nickel were unsuccessful.  
From the mercurial chloride, there are many options to effect the cyclization.  Treatment 
of the mercurial chloride with bromine should form the alkyl bromide, which could 
undergo the requisite cyclopropane formation with palladium.  Alternatively, 
cyclopropane formation need not be an isolated compound, but rather an intermediate in a 
















Alternative Cyclization Method 
 
 In 1986 Stork described his work on the interesting result that vinyl radicals 
appeared to cyclize in a 6-endo instead of a 5-exo fashion.23  It was shown that this 
process was not the case and a 5-exo cyclization followed by rearrangemnt was operative 
(Figure 29).  Addition of tributyltin radical to a dilute solution of enyne 56 resulted in 
radical 57, which then underwent a 5-exo cyclization to yield primary radical 58.  Closure 
to form cyclopropane 59 and fracturing of the internal cyclopropane bond reveals radical 
60, which is identical to the product of a 6-endo cyclization.  It is possible that as an 
alternative to the proposed radical cleavage of a vinyl cyclopropane, we might use a 
similar technique to obtain the desired radicals.   
 
Figure 29. Stork’s radical rearrangement of homoallylic radicals 
 
  
 For the purposes of platensimycin, a structure such as bicycle 61, with a group 
(X) that is capable of homolytic cleavage could be transformed into radical 62 (Figure 
30).  A 3-exo trig cyclization followed by cyclopropane rupture would yield the stabilized 









(compare to 33 in Figure 19).  Two sequential 5-exo trig cyclizations going through 
intermediate 65 would result in radical 66, which would terminate to afford tetracycle 67.  
Further elaboration would reveal the desired core of platensimycin. 
 




 This chapter describes progress toward the total synthesis of platensimycin.  The 
first–generation synthesis focused on a formal [3+2] cycloaddition between a vinyl 
cyclopropane and an olefin through a biradical intermediate.  The inability to form the 
biradical allowed us to pursue a stepwise approach with radical catalysts.  Various radical 
conditions were tested with the thiolacetic radical causing cyclopropane rupture, but not 
complete cyclization.  A revised route was created, but installation of the cyclopropane 
proved difficult.  It is possible that alternative methods will be studied toward the pursuit 

























1 Butler, M. J. Nat. Prod. 2004, 67, 2141-2153. 
 2 Klayman, D. L.; Griffin, T. S.; Bower, J. D.; Page, S. W. J. Med. Chem. 1973, 16, 1042-
1043.  
3 Singh, S. B.; Barrett, J. F. Biochem. Pharmacol. 2006, 71, 1006-1015. 
 
4 Neu H. C. Science 1992, 257, 1064-1073. 
 
5 Fleming, A. Brit. J. Exp. Path. 1929, 10, 226-236. 
 
6 Chain, E.; Florey, H. W.; Gardner, A. D.; Heatly, N. G.; Jennings, M. A.; Orr-Ewing, J.; 
Sanders, A. G. Lancet 1940, 239, 226-228. 
 
7 Du Vigneaud, V.; Carpenter, F. H.; Holley, R. W.; Livermore, A. H.; Rachele, J. R. 
Science 1946, 104, 431-433 and references within. 
 
8 (a) Sheehan, J. C.; Hess, G. P. J. Am. Chem. Soc. 1955, 77, 1067-1068, (b) Sheehan, J. 
C.; Goodman, M.; Hess, G. P. J. Am. Chem. Soc. 1956, 78, 1367-1369. 
 
9 (a) Sheehan, J. C.; Henry-Logan, K. R. J. Am Chem. Soc. 1957, 79, 1262-1263, (b) 
Sheehan J. C.; Henry-Logan, K. R. J. Am Chem. Soc. 1959, 81, 3089-3094. 
 
10 (a) Corey, E. J.; Trybulski, E. J.; Melvin, L. S., Jr.; Nicolaou, K. C.; Secrist, J. A.; Lett, 
R.; Sheldrake, P. W.; Falck, J. R.; Brunelle, D. J.; Haslanger, M. F.; Kim, S.; Yoo, S. J. 
Am. Chem. Soc. 1978, 100, 4618-4620, (b) Corey, E. J.; Kim, S.; Yoo, S.; Nicolaou, K. 
C.; Melvin, L. S., Jr.; Brunelle, D. J.; Falck, J. R.; Trybulski, E. J.; Lett, R.; Sheldrake, P. 
W. J. Am. Chem. Soc. 1978, 100, 4620-4622. 
 
11 Wang, J.; Soisson, S. M.; Young, K.; Shoop, W.; Kodali, S.; Galgoci, A.; Painter, R.; 
Parthasarathy, G.; Tang, Y. S.; Cummings, R.; Ha, S.; Dorso, K.; Motyl, M.; Jayasuriya, 
H.; Ondeyka, J.; Herath, K.; Zhang, C. W.; Hernandez, L.; Allocco, J.; Basilio, A.; 
Tormo, J. R.; Genilloud, O.; Vicente, F.; Pelaez, F.; Colwell, L.; Lee, S. H.; Michael, B.; 
Felcetto, T.; Gill, C.; Silver, L. L.; Hermes, J. D.; Bartizal, K.; Barrett, J.; Schmatz, D.; 
Becker, J. W.; Cully, D.; Singh, S. B. Nature 2006, 441, 358–361. 
 
12 (a) Nicolaou, K. C.; Li, A.; Edmonds, D. J. Angew. Chem., Int. Ed. 2006, 45, 7086–
7090. (b) Nicolaou, K. C.; Edmonds, D. J.; Li, A.; Tria, G. S. Angew. Chem., Int. Ed. 
2007, 46, 3942–3945. (c) Nicolaou, K. C.; Lister, T.; Denton, R. M.; Montero, A.; 
Edmonds, D. J. Angew. Chem., Int. Ed. 2007, 46, 4712–4714. (d) Nicolaou, K. C.; Tang, 
Y.; Wang, J. Chem. Commun. 2007, 19, 1922–1923. (e) Zou, Y.; Chen, C.-H.; Taylor, C. 
D.; Foxman, B. M.; Snider, B. B. Org. Lett. 2007, 9, 1825–1828. (f) Li, P.; Payette, J. N.; 
Yamamoto, H. J. Am. Chem. Soc. 2007, 129, 9534–9535. (g) Kaliappan, K. P.; 
Ravikumar, V. Org. Lett. 2007, 9, 2417–2419. (h) Ghosh, A. K.; Kai, X. Org. Lett. 2007, 
9, 4013–4016. (i) Tiefenbacher, K.; Mulzer, J. Angew. Chem., Int. Ed. 2007, 46, 8074-
34                                                          
8075. (j) Lalic, G.; Corey, E. J. Org. Lett. 2007, 9, 4921–4923. (k) Matsuo, J.; Takeuchi, 
K.; Ishibashi, H. Org. Lett. 2008, 10, 4049– 4052. (l) Yeung, Y.-Y.; Corey, E. J. Org. 
Lett. 2008, 10, 3877–3878. (m) Tiefenbacher, K.; Mulzer, J. Angew. Chem., Int. Ed. 
2008, 47, 2548– 2555. (n) Nicolaou, K. C.; Pappo, D.; Tsang, K. Y.; Gibe, R.; Chen, D. 
Y.-K. Angew. Chem., Int. Ed. 2008, 47, 944–946. (o) Nicolaou, K. C.; Li, Ang; Edmonds, 
D. J.; Tria, G. S.; Ellery, S. P. J. Am. Chem. Soc. 2009, 131, 16905–16918. (p) McGrath, 
N. A.; Bartlett, E. S.; Sittihan, S.; Njardarson, J. T. Angew. Chem., Int. Ed. 2009, 48, 
8543–8546. (q) Nicolaou, K. C.; Li, A.; Ellery, S. P.; Edmonds, D. J. Angew. Chem., Int. 
Ed. 2009, 48, 6293–6295. (r) Yun, S. Y.; Zheng, J.-C.; Lee, D. J. Am. Chem. Soc. 2009, 
131, 8413–8415. (s) Ghosh, A. K.; Xi, K. J. Org. Chem. 2009, 74, 1163–1170. (t) 
Tiefenbacher, K.; Trondlin, L.; Mulzer, J.; Pfaltz, A. Tetrahedron 2010, 66, 6508–6513. 
(u) Eey, S. T.-C.; Lear, M. J. Org. Lett. 2010, 12, 5510–5513. (v) Oblak E. Z.; Wright D. 
L. Org. Lett. 2011, 13, 2263–2265. 
 
13 Herath, K. B.; Attygalle, A. T.; Singh, S. B. J. Am. Chem. Soc. 2007, 129, 15422-
15423. 
 
14  Crimmins, M. T.; Choy, A. L. J. Am. Chem. Soc. 1999, 121, 5653-5560. 
 
15 (a) Katz, T. J.; Sivavec, T. M. J. Am. Chem. Soc. 1985, 107, 737-738. (b) Korkowski, 
P. F.; Hoye, T. R.; Rydberg, D. B. J. Am. Chem. Soc. 1988, 110, 2676-2678. (c) Hoye, T. 
R.; Suriano, J. A. Organometallics, 1992, 11, 2044-2050. (d) Kim, S.-H.; Bowden, N.; 
Grubbs, R. H. J. Am. Chem. Soc., 1994, 116, 10801-10802. (e) Kinoshita, A.; Mori, M. 
Synlett, 1994, 1020-1022. 
 
16 Kitamura, T.; Sato, Y.; Mori, M. Adv. Syn. & Catal. 2002, 344, 678-693. 
 
17 Furukawa, J.; Kawabata, N. Tetrahedron Lett. 1966, 3353-3354. 
 
18 (a) Feldman, K. S.; Romanelli, A. L.; Ruckle, R. E., Jr.; Jean G. J. Org. Chem. 1992, 
57, 100-110, (b) Miura, K.; Fugami, K.; Oshima, K.; Utimoto K. Tetrahedron Lett. 1988, 
29, 1543-1546. 
 
19 Brown, A.; Grigg, R.; Ravishankar, T.; Thornton-Pett, M. Tetrahedron Lett. 1994, 35, 
2753-2756. 
 
20 Suffert, J.; Salem, B.; Klotz, P. J. Am. Chem. Soc. 2001, 123, 12107-12108. 
 
21 Le Tadic-Biadatti, M.-H.; Callier-Dublanchet, A.-C.; Horner, J. H.; Quiclet-Sire, B.;  
Zard, S. Z.; Newcomb, M. J. Org. Chem. 1997, 62, 559-563. 
 
22 For selected reviews see: (a) Bäckvall, J. E. Metal-Catalyzed Cross-Coupling 
Reactions, 2nd Ed.; de Meijere, A., Diederich, F., Eds.; Wiley-VCH: New York, NY, 




23 Stork, G.; Mook, R. Tetrahedron Lett. 1986, 27, 4529-4532.  
  36 
General Information.  All reactions were performed using oven-dried glassware under 
an atmosphere of dry argon.  Non-aqueous reagents were transferred by syringe under 
argon.  Organic solutions were concentrated using a Büchi rotary evaporator. Diethyl 
ether, tetrahydrofuran, benzene, toluene, and methylene chloride (DCM) were dried using 
a J.C. Meyer solvent purification system.  Triethylamine and N,N-diisopropylethylamine 
were freshly distilled over CaH2 under argon.  All other commercial reagents were used 
as provided.  Flash column chromatography was performed employing 32-63 μm silica 
gel (Dynamic Adsorbents Inc).  Thin-layer chromatography (TLC) was performed on 
silica gel 60 F254 plates (EMD). 
 1H and 13C NMR were recorded in CDCl3 on Bruker DRX-300, DRX-400, or 
DRX-500 spectrometers as noted.  Data for 1H NMR are reported as follows: chemical 
shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
integration, coupling constant (Hz), and assignment.  Data for 13C NMR are reported in 
terms of chemical shift. IR spectra were recorded on a Nicolet Avatar 370 DTGS 
(Thermo) using NaCl salt plates.  High-resolution mass spectra (HRMS) were acquired at 
the Columbia University Mass Spectral Core Facility on a JEOL HX100 mass 









5-Octeonoic acid (8):  n-BuLi (27 mL, 59.5 mmol, 2.2 M in hexanes) was added 
dropwise to a solution of HMDS (13.6 mL, 65 mmol) in 70 mL THF at 0 °C.  After 20 
min, the solution was cannulated into a suspension of (4-
Carboxybutyl)triphenylphosphonium bromide (1g, 27 mmol) in 100 mL THF at 23 °C.  
After 30 min, propionaldehyde (3.9 mL, 54 mmol) was added and the solution stirred for 
one hour and 120 mL H2O was added.  The solution was washed with Et2O, acidified to 
pH 1 with 3 N HCl, extracted into Et2O (3 x 150 mL), dried over MgSO4 and 
concentrated.  The residue was purified via silica gel chromatography (30% EtOAc: 1% 
AcOH in hexanes) to yield the product as a mixture of olefin isomers (3.53 g, 24.9 mmol, 




Methyl 5-octenoate (9): TMSCHN2 (15 mL, 29.9 mmol, 2 M in Et2O) was added 
dropwise to a solution of 5-octenoic acid (3.53 g, 24.9 mmol) in a mixture of 45 mL 
MeOH and 110 mL toluene.  The solution was stirred for an additional hour once the 
yellow color persisted.  The solution was concentrated a purified by silica gel                                                         
1 Hudrlik, P. F.; Hudrlik, A, M.; Yimenu, T.; Waugh, M. A.; Nagendrappa, G. 








chromatography (20% EtOAc in hexanes) to yield the title compound (3.26 g, 20.9 
mmol, 84%).  1H NMR (300 MHz, CDCl3) δ 5.43 (m, 1H, olefin) 5.26 (m, 1H, olefin), 
3.67 (s, 3H, CH3O2C), 2.31 (t, 2H, J = 7.5 Hz, CH3O2CCH2), 2.30 (isomer, t, 2H, J = 7.5 
Hz, CH3O2CCH2), 2.02 (m, 4H, CH2CHCHCH2), 1.68 (pentet, 2H, J = 7.2 Hz, 





3-Butenal:  octa-1,7-diene-4,5-diol2 (1.85 g, 13 mmol) was dissolved in 13 mL DCM and 
cooled to 0 °C.  pH 4.6 acetate buffer (13 mL) was added followed by sodium periodate 
(2.78 g, 13 mmol).  After 4 hrs, the reaction was filtered through a glass frit.  The organic 





syn-Methyl 2-(1-hydroxybut-3-enyl)oct-5-enoate (10): Methyl 5-octenoate (2.48 g, 
15.9 mmol) was dissolved in 80 mL DCM and cooled to –78 °C.  N,N-                                                        







Diisopropylethylamine (4.12 mL, 23.9 mmol) was added to the solution followed by the 
addition of Bu2BOTf (20.6 mL, 20.6 mmol, 1 M in DCM).  The solution became bright 
yellow.  After 3.5 hrs the 3-butenal solution was added and the reaction was stirred for 3 
hrs, at which time pH 7 buffer was added.  The solution was warmed to 23 °C, extracted 
into Et2O (3 x 100 mL) and concentrated.  The residue was dissolved in 50 mL MeOH, 
cooled to 0 ˆC, and 11 mL 35% H2O2 was added.  After 3 hrs, 10 mL H2O was added, the 
solution was extracted into Et2O, washed with 5% NaHCO3, dried over MgSO4 and 
concentrated.  The residue was purified by silica gel chromatography (20% EtOAc in 
hexanes) to yield the product as a single diastereomer (2.77 g, 12.2 mmol, 77%).  1H 
NMR (400 MHz, CDCl3) δ 5.78 (m, 1H, vinyl), 5.43-5.21 (m, 2H, olefin), 5.11 (bd, 1H, 
J = 3.2 Hz, vinyl), 5.08 (d, 1H, J = 0.8 Hz, vinyl), 3.78 ((m, 1H, CHOH), 3.67 (s, 3H, 
CH3O2C), 2.47 (ddd, 1H, J = 9.6, 5.2, 4.4 Hz, CH3O2CCH), 2.38 (bs, 1H, OH), 2.20 (m, 
2H, CH2CHCH2), 1.98 (m, 4H, CH2CHCHCH2), 1.71 (m, 2H, CHCH2CH2), 0.91 (t, 3H, 
J = 7.2 Hz, CH2CH3); 13C NMR (100 MHz, CDCl3) δ 175.90, 175.89, 134.69, 133.52, 
133.09, 118.19, 71.56, 52.00, 50.45, 50.31, 39.42, 39.37, 30.90, 27.79, 27.64, 25.93, 
25.50, 20.88, 14.63, 14.20; IR (thin film) ν 3458, 3006, 2962, 2934, 1734, 1642, 1436, 
1202, 1165 cm-1; HRMS (FAB+) exact mass calc’d for C13H23O3+ [M+H+] requires 








syn-Methyl 2-(1-(tert-butyldimethylsilyloxy)but-3-enyl)oct-5-enoate (11):  Imidazole 
(1.68 g, 24.7 mmol) was added to a solution of syn-Methyl 2-(1-hydroxybut-3-enyl)oct-
5-enoate (1.86 g, 8.22 mmol) in 24 mL of DMF.  After 10 min, TBSCl (2.48 g, 16.4 
mmol) was added and the solution was stirred overnight.  The reaction was quenched 
with 1 N HCl, extracted into EtOAc (2 x 100 mL), washed with sat. NaHCO3 and brine.  
The solution was dried over Na2SO4, filtered, and concentrated.  The residue was then 
purified by silica gel chromatography (10% EtOAc in hexanes) to yield the silyl ether 
(2.75 g, 8.07 mmol, 95%). 1H NMR (300 MHz, CDCl3) δ 5.78 (dddd, 1H, J = 14.4, 11.1, 
7.2, 7.2, CHCH2), 5.50-5.25 (m, 2H, CHCH), 5.07 (s, 1H, CHCH2), 5.02 (d, 1H, J = 5.4 
Hz, CHCH2), 3.92 (apparent qt, 1H, J = 6 Hz, CHOTBS), 3.66 (s, 3H CH3O), 2.51 (ddd, 
1H, J = 10.2, 6.3, 3.9, CH3O2CCH), 2.26 (m, 2H, CH2CHCH2), 1.98 (m, 4H, 
CH2CHCHCH2), 1.65 (m, 2H, CHCH2CH2), 0.94 (t, 3H, J = 7.5 Hz, CH2CH3), 0.91 










syn-2-(1-(tert-butyldimethylsilyloxy)but-3-enyl)oct-5-en-1-ol (11a):  DIBAL (14 mL, 
14 mmol, 1 M in hexanes) was added to a solution of syn-Methyl 2-(1-(tert-
butyldimethylsilyloxy)but-3-enyl)oct-5-enoate (2.13 g, 6.26 mmol) in 31 mL toluene.  
After 45 min, 30 mL sat. Rochelle’s salt was added and the solution was left to stir 
overnight.  The layers were then separated.   The aqueous layer was extracted into EtOAc 
then the organics were combined, dried over Na2SO4, and filtered.  The filtrate was 
concentrated and then purified via silica gel chromatography to yield the alcohol (1.75 g, 
5.6 mmol, 89%). 1H NMR (300 MHz, CDCl3) δ 5.79 (dddd, J = 14.4, 10.2, 7.2, 7.2 Hz, 
CHCH2), 5.35, (m, 2H, CHCH), 5.07 (dd, 1H, J = 14.2, 1.5 Hz, CHCH2), 5.05 (dd, J = 
10.2, 1.5 Hz, CHCH2), 3.89 (ddd, 1H, J = 8.1, 5.4, 5.1 Hz, CHOTBS), 3.74 (ddd, 1H, J = 
10.8, 10.8, 3 Hz, CH2OH), 3.63 (ddd, 1H, J = 6.9, 6.9, 4.2 Hz, CH2OH), 3.06 (isomer, dd, 
J = 7.2, 3.0 Hz), 2.99 (dd, J = 6.9, 3.0 Hz), 2.26 (m, 2H, CH2CHCH2), 2.03 (m, 4H, 
CH2CHCHCH2), 1.87 (m, 1H), 1.20 (m. 2H, CHCH2CH2), 0.97 (t, 3H, J = 6.3 Hz, 








syn-2-(1-(tert-butyldimethylsilyloxy)but-3-enyl)oct-5-enal (12): A mixture of syn-2-(1-
(tert-butyldimethylsilyloxy)but-3-enyl)oct-5-en-1-ol (5 g, 16 mmol), 4-methylmorpholine 
N-oxide (2.81 g, 24 mmol), and ground 4Å molecular sieves (2 g) was stirred in 74 mL of 
DCM for 20 min.  Tetrapropylammonium perruthenate (250 mg, .71 mmol) was added 
and the solution was placed into an ice bath.  The reaction was stirred for 1 hr, then 
purified by a silica gel plug utilizing DCM as eluent to yield the title aldehyde (4.31 g, 
13.9 mmol, 87%).  1H NMR (400 MHz, CDCl3) δ 9.77 (d, 1H, J = 1.5 Hz, CHO), 5.73, 
(dddd, J = 13.6, 10.2, 7.2, 7.2 Hz, CHCH2), 5.42-5.22 (m, 2H, CHCH), 5.06 (bs, 1H, 
CHCH2), 5.03 (m, 1H, CHCH2), 4.06 (apparent qt, 1H, J = 6.4 Hz, CHOTBS), 2.40 (m, 
1H, CH2CHCH2), 2.22 (m, 4H, CH2CHCHCH2), 2.08-1.93 (m, 4H, aliphatic), 1.82 (m, 
1H, aliphatic), 1.45 (m, 1H, aliphatic), 0.92 (t, 3H, J = 7.6 Hz, CH2CH3), 0.85 (s, 9H, 
OTBS), 0.04 (s, 3H, OTBS), 0.02 (s, 3H, OTBS); 13C NMR (100 MHz, CDCl3) δ 
205.34, 205.19, 134.45, 134.36, 133.34, 132.87, 128.18, 128.07, 117.99, 117.94, 72.06, 
56.16, 55.96, 39.55, 39.45, 30.55, 25.81, 25.60, 25.20, 24.16, 23.99, 20.60, 18.06, 14.32, 
13.87, –4.25, –4.71; IR (thin film) ν 3070, 2956, 2926, 2850, 1717, 1630, 1464, 1351, 
1259, 1075 cm-1; HRMS (FAB+) exact mass calc’d for C18H35O2Si+ [M+H+] requires 








tert-butyl(syn-5-(2,2-dibromovinyl)undeca-1,8-dien-4-yloxy)dimethylsilane (12a): A 
solution of CBr4 (18.4 g, 55.6 mmol) in 54 mL of DCM was added dropwise to a solution 
of PPh3 (21.9 g, 83.4 mmol) in 54 mL of DCM at 0 °C.  After 30 min, a solution of syn-2-
(1-(tert-butyldimethylsilyloxy)but-3-enyl)oct-5-enal (4.31 g, 13.9 mmol) in 27 mL of 
DCM was added and stirred for 1 hr.  The reaction was poured directly onto a pad of 
silica gel wetted with hexanes.  The solution was filtered with 2.5 % EtOAc in hexanes.  
The filtrate was concentrated and purified by silica gel chromatography (2.5 % EtOAc in 
hexanes) to yield the dibromoolefin (5.64 g, 12.1 mmol, 87%).  1H NMR (300 MHz, 
CDCl3) δ 6.28 (d, 1H, J = 9.6 Hz, CHCBr2), δ 6.22 (isomer, d, 1H, J = 9.9 Hz, CHCBr2), 
5.76 (m, 1H, CHCH2), 5.50-5.24 (m, 2H, CHCH), 5.09 (d, 1H, J = 3.9 Hz, CHCH2), 5.04 
(bs, 1H, CHCH2), 3.70 (m, 1H, CHOTBS), 2.48 (m, 1H, CH2CHCH2), 2.26 (m, 1H, 
CH2CHCH2), 2.03 (m, 4H, CH2CHCHCH2), 1.60 (m 1H, CHCH2CH2), 1.39 (m 1H, 
CHCH2CH2), 0.96 (t, 3H, J = 7.5 Hz, CH2CH3), 0.88 (s, 9H, OTBS), 0.05 (s, 3H, OTBS), 
0.04 (s, 3H, OTBS); 13C NMR (100 MHz, CDCl3) δ 141.57, 134.54, 132.39, 128.58, 
117.50, 88.84, 73.88, 48.06, 39.81, 30.12, 28.25, 25.94, 24.79, 20.67, 18.11, 14.44, 14.03, 
–4.13, –4.61; IR (thin film) ν 3077, 3006, 2957, 2930, 2857, 2640, 1619, 1471, 1462, 
1361, 1255 cm-1; HRMS (FAB+) exact mass calc’d for C19H35Br2OSi+ [M+H+] requires 








tert-butyl(syn-5-ethynylundeca-1,8-dien-4-yloxy)dimethylsilane (6): n-BuLi (30.3 mL, 
30.3 mmol, 2.5 M in hexanes) was added dropwise to a solution of tert-butyl(syn-5-(2,2-
dibromovinyl)undeca-1,8-dien-4-yloxy)dimethylsilane (5.64 g, 12.1 mmol) in 240 mL 
THF at –78 °C.  After 40 min, the reaction was quenched with sat. NH4Cl and warmed to 
23 °C.  The aqueous layer was extracted into DCM then the organics were combined and 
dried over Na2SO4.  The solution was filtered and concentrated to yield the alkyne (3.68 
g, 12 mmol, 99%) that was used without further purification. 1H NMR (400 MHz, 
CDCl3) δ 5.84 (dddd, J = 14.4, 10.0, 7.2, 7.2 Hz, CHCH2), 5.50-5.26 (m, 2H, CHCH), 
5.10-5.04 (m, 2H, CHCH2), 3.69 (apparent qt, J = 4.8 Hz, CHOTBS), 2.45 (m, 2H, 
aliphatic), 2.35-2.16 (m, 3H, aliphatic), 2.07-1.98 (m, 3H, alkynyl and aliphatic), 1.61 (m, 
1H, aliphatic), 1.43 (m, 2H, aliphatic), 1.31 (m, 1H, aliphatic), 0.95 (t, 3H, J = 7.6 Hz, 
CH2CH3), 0.89 (s, 9H, OTBS), 0.06 (s, 6H, OTBS); 13C NMR (100 MHz, CDCl3) δ 
134.66, 134.55, 132.80, 132.61, 128.40, 128.33, 117.50, 85.45, 73.98, 70.97, 41.72, 
39.37, 39.26, 37.37, 37.26, 30.72, 30.51, 30.19, 25.97, 25.00, 23.41, 20.65, 18.22, 14.45, 
14.20, 14.02, –4.12, –4.50; ; IR (thin film) ν 3311, 3077, 2929, 2930, 2857, 2250, 1641, 








butyl(syn-5-ethynylundeca-1,8-dien-4-yloxy)dimethylsilane (3.69 g, 12 mmol) and 
Grubbs 1st generation catalyst (395 mg, 0.48 mmol) was heated to 45 °C in 220 mL 
benzene for 1.5 hrs.  The solution was concentrated and purified via silica gel 
chromatography (1 % EtOAc in hexanes) to yield the pure bicycle (2.76 g, 11 mmol, 
92%).  1H NMR (300 MHz, CDCl3) δ 6.14 (d, 1H, J = 9.9 Hz, olefinic), 5.77 (m, 1H, 
olefinic), 5.29 (bs, 1H, olefinic), 4.04 (apparent qt, 1H, J = 8.1 Hz, CHOTBS), 2.49 (m, 
2H, aliphatic), 2.33-2.09 (m, 5H, aliphatic), 1.24 (m, 1H, aliphatic), 0.90 (s, 9H, OTBS), 
0.06 (s, 3H, OTBS), 0.05 (s, 3H, OTBS); 13C NMR (75 MHz, CDCl3) δ 139.97, 130.56, 




(1,7a-syn)-2,6,7,7a-tetrahydro-1H-inden-1-ol (5): Pyridinium p-toluenesulfonate (50 
mg, 0.2 mmol) was added to a solution of tert-butyldimethyl((1,7a-syn)-2,6,7,7a-
tetrahydro-1H-inden-1-yloxy)silane (500 mg, 2.0 mmol) in a mixture of 66 mL MeOH 
and 6.6 mL THF.  The solution was heated to 45 °C overnight.  The reaction was 






1.79 mmol, 90%), which must be used quickly for decomposition occurs.  1H NMR (300 
MHz, CDCl3) δ 6.16 (d, 1H, J = 10.2 Hz, olefinic), 5.80 (m, 1H, olefinic), 5.31 (d, 1H, J 
= 2.7 Hz, olefinic), 4.12 (apparent qt, 1H, J = 8.1 Hz, CHOH), 2.67 (ddd, 15.9, 7.5, 2.7 
Hz, aliphatic), 2.50 (m, 1H, aliphatic), 2.32 (dd, 1H, J = 17.1, 8.4 Hz, aliphatic), 2.19 (m, 




(1,3,3a,7a-syn)-3,3a-cyclopropyl-2,3,3a,6,7,7a-hexahydro-1H-inden-1-ol (23):  
Diiodomethane (318 µL, 3.94 mmol) was added to a solution of diethylzinc (1.97 mL, 
1.97 mmol, 1 M in hexanes) in 60 mL of DCM at 0 °C.  After 20 min, (1,7a-syn)-
2,6,7,7a-tetrahydro-1H-inden-1-ol (244 mg, 1.79 mmol) in 21 mL of DCM was added 
and the reaction was stirred for 30 min, at which time the temperature was raised to 23 
°C.  After an additional 2 hrs, the reaction was quenched with sat. NH4Cl, extracted into 
EtOAc, dried over Na2SO4, and concentrated.  The residue was purified via silica gel 
chromatography to yield the tricycle (230 mg, 1.53 mmol, 85%), which was used 










indene (4): Pyridinium p-toluenesulfonate (small crystal) was added to a solution of 
(1,3,3a,7a-syn)-3,3a-cyclopropyl-2,3,3a,6,7,7a-hexahydro-1H-inden-1-ol (230 mg, 1.53 
mmol) and 2-methoxypropene (360 µL, 3.75 mmol) in 5.3 mL of DCM at 0 °C.  After 15 
min, Et3N (320 µL, 2.3 mmol) was added, the temperature was raised to 23 °C, and 
TMSOTf (345 µL, 2 mmol) was added.  The reaction was stirred overnight, concentrated, 
and passed through a neutral alumina column with hexanes to yield the title compound 
(212 mg, 1.11 mmol, 72%).  1H NMR (300 MHz, CDCl3) δ 5.68 (m, 1H, olefinic), 5.24 
(d, 1H,  J = 9.9 Hz), 4.10 (d, 1H, J = 6.6 Hz, CHO), 3.83 (s, 1H, enol ether), 3.62 (s, 1H, 
enol ether), 2.10 (m, 4H), 1.75 (s, 3H, CH3C(CH2)O), 1.29 (m, 4H, aliphatic and 
cyclopropyl), 1.07 (t, 1H, J = 4.5 Hz, cyclopropyl), 0.65 (dd, 1H, J = 8.4, 4.5 Hz, 
cyclopropyl). 
 
Attempted radical cyclization: The cyclization substrate (20 mg, 0.11 mmol), 
thiolacetic acid (catalytic or stoichiometric amounts), and AIBN (3.6 mg, 0.02 mmol) in 
benzene (1 mL) was freeze-pumped-thawed to deoxygenate the solution.  The reaction 











(R*)-1-((R*)-2-bromocyclohex-2-enyl)prop-2-yn-1-ol (43a): To a solution of (1S*)-
1[(1R*)-2-bromocyclohex-2-en-1-yl]-3-(trimethylsilyl)prop-2-yn-1-ol3 (933 mg, 3.25 
mmol) in anhydrous methanol (10 mL) was added a solution of sat. K2CO3 in methanol (5 
mL).  After stirring for 1 hr, sat, NH4Cl was added and the reaction mixture was diluted 
with EtOAc.  The organic layer was washed with water, dried over Na2SO4, filtered, and 
concentrated.  The crude product was purified via silica gel chromatography to yield the 
terminal alkyne (586 mg, 2.72 mmol, 84%).  1H NMR (300 MHz, CDCl3) δ 6.29 (ddd, 
1H, J = 4.5, 4.5, 2.1 Hz, vinyl), 5.01 (m, 1H, propargylic), 2.55 (m, 1H, allylic), 2.48 (d, 
1H, J = 2.4 Hz, acetylenic), 2.19 (d, 1H, J = 4.8 Hz, OH), 2.06 (m, 2H, allylic), 2.01 (m, 
2H, alkyl), 1.85 (m, 1H, alkyl), 1.55 (m, 1H, alkyl); 13C NMR (75 MHz, CDCl3) δ 134.5, 
123.0, 82.8, 74.1, 63.6, 47.6, 27.7, 24.6, 20.4; IR (thin film) ν 3439, 3285, 2930, 2112, 












cyclohex-2-enyl)prop-2-yn-1-ol (1.16 g, 5.39 mmol) and Lindlar catalyst (130 mg) were 
diluted with EtOAc (100 mL).  The reaction was stirred under 1 atm of H2 for 16 hrs and 
then filtered through a pad of Celite.  The filtrate was concentrated to yield pure product 
(1.09 g, 5.02 mmol, 93%).  1H NMR (300 MHz, CDCl3) δ 6.32 (ddd, 1H, J = 4.2, 4.2, 1.8 
Hz, vinyl), 5.88 (ddd, 1H, J = 17.4, 10.8, 4.8 Hz, vinyl), 5.35 (dd, 1H, J = 17.4, 1.8 Hz, 
vinyl), 5.22 (dd, 1H, J = 10.5, 1.8 Hz, vinyl), 4.79 (m, 1H, CHOH), 2.47 (m, 1H, allylic), 
2.05 (m, 2H, allylic), 1.78 (m, 3H, alkyl), 1.66 (bs, 1H, OH), 1.53 (m, 1H, alkyl); 13C 
NMR (75 MHz, CDCl3) δ 138.5, 134.2, 125.0, 115.2, 72.6, 47.6, 27.8, 23.8, 20.6; IR 




(S*)-1-((R*)-2-bromocyclohex-2-enyl)propane-1,3-diol (45): BH3•DMS (600 µL, 1.26 
mmol, 2 M in THF) was added to a solution of (S*)-1-((R*)-2-bromocyclohex-2-
enyl)prop-2-en-1-ol (180 mg, 0.84 mmol) in THF (3 mL).  After 3 hrs, the reaction was 









H2O2 (1.2 mL) were added.  After stirring at 23 °C overnight, the solution was diluted 
with water, extracted into EtOAc, dried over Na2SO4, filtered, and concentrated.  The 
residue was purified via silica gel chromatography (20 to 40% EtOAc in hexanes) to 
yield the diol (122 mg, 0.52 mmol, 62%).  The remaining mass was recovered as the 
regioisomeric diol resulting from a substrate directed hydroboration-oxidation. 1H NMR 
(400 MHz, CDCl3) δ 6.26 (t, 1H, J = 4.4, Hz, vinyl), 4.39 (bd, 1H, J = 10 Hz, CHOH), 
3.81 (t, 2H, J = 6.0 Hz, CH2OH), 3.18 (bs, 1H, OH), 2.67 (bs, 1H, OH), 2.32 (m, 1H, 
allylic), 2.02 (m, 2H, allylic), 1.83 (m, 4H, alkyl), 1.56 (m, 2H, alkyl); 13C NMR (100 
MHz, CDCl3) δ 133.8, 125.4, 71.3, 61.5, 47.7, 35.3, 27.6, 23.7, 20.4; IR (thin film) ν 
3377, 2923, 2860, 1637, 1435, 1085, 1043 cm-1; HRMS (FAB+) exact mass calc’d for 





Imidazole (69 mg, 1.02 mmol) was added to a solution of (S*)-1-((R*)-2-bromocyclohex-
2-enyl)propane-1,3-diol (87 mg, 0.37 mmol) in DMF (1 mL).  After 5 min, 
triisopropylsilyl chloride (103 µL, 0.44 mmol) was added and the solution was stirred for 
3 hrs.  At this time Et2O was added, the solution was washed with water and brine, then 
dried over MgSO4, and concentrated.  The crude mixture was purified by silica gel 






MHz, CDCl3) δ 6.28 (ddd, 1H, J = 3.6, 1.5, 1.5 Hz, vinyl), 4.46 (dd, 1H, J = 9.9, 2.4 Hz, 
CHOH), 3.95 (m, 2H, CH2OTIPS), 2.89 (d, 1H, J = 2.1 Hz, OH), 2.34 (m, 1H, allylic), 




(S*)-1-((R*)-2-bromocyclohex-2-enyl)-3-(triisopropylsilyloxy)propyl acetate (47): 
Acetic anhydride (42 µL, 0.45 mmol) was added to a solution of (S*)-1-((R*)-2-
bromocyclohex-2-enyl)-3-(triisopropylsilyloxy)propan-1-ol (130 mg, 0.33 mmol), Et3N 
(92 µL, 0.33 mmol), and N,N-4-dimethylaminopyridine (3 mg) in DCM (1.6 mL).  After 
4 hrs, water was added, the solution was extracted into EtOAc, dried over Na2SO4, and 
concentrated.  Silica gel chromatography (2.5% EtOAc in hexanes) afforded the pure 
product (100 mg, 0.23 mmol, 70%). 1H NMR (300 MHz, CDCl3) δ 6.20 (ddd, 1H, J = 
4.2, 1.5, 1.5 Hz, vinyl), 45.48 (ddd, 1H, J = 6, 6, 2.4 Hz, CHOH), 3.74 (m, 2H, 
CH2OTIPS), 2.63 (m, 1H, allylic), 2.06 (m, 2H, allylic), 2.02 (s, 3H, acetate), 1.87 (m, 












(S*)-3-((R*)-2-bromocyclohex-2-enyl)-3-hydroxypropanoic acid (49): To a solution of 
(1S*)-1[(1R*)-2-bromocyclohex-2-en-1-yl]-3-(trimethylsilyl)prop-2-yn-1-ol3 (200 mg, 
0.7 mmol) in THF (3.5 mL) was added BH3•DMS (390 µL, 2.0 M in THF, 0.77 mmol) 
and was stirred for 2 hrs.  Excess borane was quenched with MeOH (1.1 mL) and stirred 
for 30 min.  The solution was cooled to 0 °C and then 2 N NaOH (500 µL) and 35% H2O2 
(500 µL) were added.  After 20 min, the temperature was raised to 40 °C and the solution 
stirred for an additional 2 hrs.  The temperature was returned to 23 °C and the solution 
was made homogeneous by the addition of 2 N NaOH.  The solution was then washed 
with Et2O and the organic layer was reextracted with water.  The combined aqueous 
solutions were acidified with 3 N HCl until pH 3 and extracted into EtOAc, dried over 
Na2SO4, and concentrated.  The product was used without further purification (162 mg, 
0.66 mmol, 94%).  1H NMR (300 MHz, CDCl3) δ 7.50 (bs, 1H, COOH), 6.34 (td, 1H, J 
= 4.8, 1.5  Hz, vinyl), 4.70 (dt, 1H, J = 10.2, 3 Hz, OCH), 2.99 (s, 1H, OH), 2.71 (dd, 1H, 
J = 16.5, 9.9 Hz, CH2C(O)), 2.49 (dd, 1H, J = 16.2, 3 Hz, CH2C(O)), 2.44 (m, 1H, 












(50): To a solution of (S*)-3-((R*)-2-bromocyclohex-2-enyl)-3-hydroxypropanoic acid 
(200 mg, 0.8 mmol) in DCM (3 mL) at 0 °C was added N,O-Dimethylhydroxylamine 
hydrochloride (101 mg, 1.04 mmol) and 4-methylmorpholine (114 µL, 1.04 mmol).  
After 5 min, small portions of N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC•HCl) (199 mg, 1.04 mmol) were added over 10 min.  After 2.5 hrs, 
the solution was diluted with DCM, washed with 1 N HCl, sat. NaHCO3, then dried over 
MgSO4, and concentrated.  The residue was purified by silica gel chromatography (35% 
EtOAc in hexanes) to yield the pure Weinreb amide (192 mg, 0.66 mmol, 83%).  1H 
NMR (400 MHz, CDCl3) δ 6.14 (m, 1H, vinyl), 4.50 (ddd, 1H, J = 9.6, 3.2, 3.2 Hz, 
CHOH), 3.61 (s, 3H, OCH3), 3.42 (bs, 1H, OH), 3.09 (s, 3H, NCH3), 2.59 (m, 1H, 
CH2C(O)), 2.48 (m, 1H, CH2C(O)), 2.27 (bm, 1H, allylic CH), 1.96 (m, 2H, allylic CH2), 
1.84 (m, 1H, cyclohexyl), 1.73 (m, 1H, cyclohexyl), 1.65 (m, 1H, cyclohexyl), 1.45 (m, 
1H, cyclohexyl); 13C NMR (100 MHz, CDCl3) δ 173.0, 132.6, 125.0, 67.7, 60.9, 46.5, 
35.6, 31.5, 27.2, 23.6, 19.7; IR (thin film) ν 3443, 2939, 2865, 1634, 1434, 1327, 1182, 













methyl-propanamide (536 mg, 1.83 mmol), potassium isopropenyltrifluoroborate (407 
mg, 2.75 mmol), cesium carbonate (1.79 g, 5.5 mmol) and PdCl2(dppf)•DCM (149 mg, 
0.18 mmol) were placed in a flask and the atmosphere was replaces with argon.  Then 
cyclopentyl methyl ether (24 mL) and degassed water (2.4 mL) was introduced.  The 
reaction was heated to 80 °C overnight.  Then the solution was diluted with water, 
extracted into Et2O, dried over MgSO4, and concentrated.  The residue was purified by 
silica gel chromatography (50 to 75% Et2O in hexanes) to yield the diene (380 mg, 1.50 
mmol, 82%).  1H NMR (300 MHz, CDCl3) δ 5.95 (t, 1H, J = 4.2 Hz, internal vinyl), 4.94 
(s, 1H, external vinyl), 4.88 (s, 1H, external vinyl), 4.17 (m, 1H, OCH), 3.66 (s, 3H, 
OCH3), 3.20 (bs, 1H, OH), 3.16 (s, 3H, NCH3), 2.61 (m, 3H, allylic and CH2C(O)), 2.14 
(m, 2H, allylic), 2.05 (m, 1H, cyclohexyl), 1.89 (s, 3H, CCH3), 1.83 (m, 1H, cyclohexyl), 













yl)ethanamide (52):  Pd(OAc)2 (1 mg, 004 mmol), Cu(OAc)2 (18.2 mg, 0.1 mmol) and 
anhydrous Na2HPO4 (28.4 mg, 0.2 mmol) were combined in a dry flask under argon.  A 
solution of (S*)-3-hydroxy-N-methoxy-N-methyl-3-((S*)-2-(prop-1-en-2-yl)cyclohex-2-
enyl)propanamide (10 mg, 0.04 mmol) in dry DMSO (2 mL) was added and the solution 
was heated to 65 °C for 30 min.  The cooled solution was diluted with water, extracted 
into EtOAc, washed with sat NaHCO3, dried over MgSO4, and concentrated.  The residue 
was purified by silica gel chromatography (50% EttO in hexanes) to yield the product 
(8.3 mg, 0.033 mmol, 83%).  1H NMR (400 MHz, CDCl3) δ 5.32 (s, 1H, vinyl), 5.10 (s, 
1H, vinyl), 4.73 (m, 1H, OCH), 3.62 (s, 3H, NOCH3), 3.16 (s, 3H, NCH3), 2.77 (m, 2H, 
bridgehead and CH2C(O)), 2.27 (dd, 1H, J = 15.2, 3.6 Hz, CH2C(O)), 2.06 (m, 2H, 
allylic), 1.75 (m, 2H, cyclohexyl), 1.72 (s, 3H, CCH3), 1.52 (m, 1H, cyclohexyl), 1.05 
(qd, 1H, J = 12.4, 2.8 Hz, cyclohexyl); 13C NMR (100 MHz, CDCl3) δ 172.4, 149.0, 
129.7, 118.3, 101.5, 74.6, 61.1, 37.1, 32.2, 30.4, 25.3, 24.6, 22.6, 20.1.  Structure 












hexahydroisobenzofuran-1-yl)methyl)mercury(II) chloride (55): To a solution of 
(S*)-3-hydroxy-N-methoxy-N-methyl-3-((S*)-2-(prop-1-en-2-yl)cyclohex-2-enyl)propan-
amide (50 mg, 0.2 mmol) in MeCN at –20 °C was added Hg(OAc)2.  After 20 min., brine 
was added and the reaction was stirred for 10 min. and then at 23 °C for 10 min.  The 
solution was diluted with DCM, washed with water, and the aqueous was reextracted 
with DCM.  The combined organic layers were dried over MgSO4, filtered, and 
concentrated.  The diastereomers were separated by silica gel chromatography (75% Et2O 
in hexanes) to yield the desired diastereomer (61 mg, 0.13 mmol, 63%).  1H NMR (400 
MHz, CDCl3) δ 5.59 (bs, 1H, vinyl), 4.81 (apparent q, 1H, J = 7.6 Hz, OCH), 3.63 (s, 3H, 
NOCH3), 3.17 (s, 3H, NCH3), 3.09 (m, 1H, bridgehead), 2.47 (dd, 1H, J = 15.6, 7.6 Hz, 
CH2C(O)), 2.36 (dd, 1H, J = 15.6, 6.4 Hz, CH2C(O)), 2.27 (s, 2H, JH-Hg = 93 Hz, CH2Hg), 
2.06 (m, 2H, allylic), 1.84 (m, 2H, cyclohexyl), 1.44 (s, 3H, CCH3), 1.44 (m, 1H, 
cyclohexyl), 1.02 (qd, 1H, J = 12, 2.4 Hz, cyclohexyl); 13C NMR (100 MHz, CDCl3) δ 










































































Chapter 2  
Carbon as a Leaving Group: 
Leaving Group Potential of the Cyclopentadienyl Anion1 
 
Leaving group (nucleofuge) stability is essential to all reactions that involve a 
heterolytic bond cleavage (i.e., substitution and elimination processes).  The nucleofuge’s 
ability to serve as the leaving group is proportional to its capability to stabilize two 
electrons.  As such, nucleofuges often take form as highly electronegative atoms (Br and 
I), resonance stabilized anions (sulfonates), or neutral species (water, alcohols, amines).  
Atoms such as carbon cannot provide the requisite stability and bond cleavage is often 
difficult.   
 The notion of using carbon as a leaving group is not completely absent from the 
literature. Common cases in synthesis include the haloform and retro-aldol reactions, 
whereby the carbon nucleofuge is rendered stable by a strong inductive effect or by 
resonance stabilization.   Additionally, steric effects can have an influence in cleavage of 
carbon-carbon bonds.  For example, it has been shown that the reaction of crotyl 
Grignard reagents and ketones will often result in the branched methallyl adduct (Figure 
1, A).  If, however, the alkyl groups about the ketone are sufficiently large (R = t-Bu), 
then it is possible for a retro-carbonyl-ene reaction to occur followed by re-addition of the 
Grignard reagent to furnish the linear product.2  In another example, palladium–mediated 
decarboxylation of aryl carboxylates has been used in cross–coupling reactions (Figure 1, 
B).3  This reaction is facilitated by the irreversible production of CO2, allowing the 
formation of the aryl-palladium species.  Researchers studying nucleophilic aromatic 
  89 
substitution reported the carbon-carbon bond cleavage of certain aryl-cyclohexyl alcohols 
(Figure 1, C).4  In addition to the desired nucleophilic aromatic substitution with 
methoxide, they noted generation of the cyclohexenone and tetrafluoroanisole.  They 
surmise that initial deprotonation of the tertiary alcohol generates an alkoxide capable of 
expelling the highly electron-deficient pentafluorophenyl anion.  This anion then rapidly 
protonates and undergoes the desired nucleophilic aromatic substitution.  These three 
reactions show how steric effects, coupling an irreversible process, and highly 
inductively stabilized groups can cause carbon–carbon bond cleavage. 
 





























X = N, O, S
Y = CH, N




















A. Rearrangement of crotyl Grignard- ketone adducts
B. Decarboxylative cross coupling
C. Pentafluorophenyl leaving group
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The Lambert group has developed a research program utilizing aromatic ions as 
promoters and catalysts for chemical transformations.  Previously, we have disclosed 
work utilizing the cyclopropenium cation as a platform for dehydrative processes.5    This 
process will be discussed in more detail in Chapter 3.  These reactions rely on the 
equilibrium between a geminal disubstituted nonaromatic cyclopropene and the 
dissociated aromatic cyclopropenium cation (Figure 2).  Different R substituents (i.e., 
alkyl, aryl, or amino) will stabilize the cation through hyperconjugation or resonance.  
These effects can shift the equilibrium of association from one side to another.    For the 
purposes of stabilizing a negative charge, an analogous equilibrium exists between a 
geminal disubstituted cyclopentadiene and its dissociated aromatic cyclopentadienyl 
anion.  In this case, electron-withdrawing groups would be advantageous to the 
stabilization of an anion.   
 
Figure 2. Aromatic ion ligand dissociation 
 
 
 In this regard, we were drawn to the cyclopentadienyl (Cp) anion as a possible 
scaffold for the development of carbon based nucleofuges (Figure 3). We felt that the 


















cleavage in our reaction paradigm.  As seen in Figure 1, the steric and electronic 
properties of the nucleofuge have a pivotal influence on its leaving group potential.  
 
Figure 3. Cyclopentadienyl anion as a leaving group 
 
 
Cp anions are most commonly found as ligands for metal complexes, and their 
properties have been well studied.6  The substitution about the ring should affect both the 
electronic properties of the aromatic system and also provide requisite steric components 
if necessary.  It is most interesting to note that substitution about the ring can have an 
extremely marked difference in the stability of the Cp anion, which can be compared by 
the pKa of the parent cyclopentadiene.  For example, successive substitution of the Cp 
ring with cyano groups can lower the pKa of the conjugate acid from 15 to < –11 (Table 
1).7  For comparison, common leaving groups such as bromide and methanesulfonate 
have pKa values of –9 and –2.6 for their conjugate acids, respectively.  If we use the pKa 
as a measure of stability, then this data shows that it is plausible that Cp anions could 



















X = halide, sulfonate, H2O, etc.
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Strongly electron deficient Cp anions, however, have been shown to be reactive 
not at the Cp ring, but rather at the substituents.8  For example, the 
pentakis(methoxycarbonyl)cyclopentadienyl anion will protonate at the ester oxygen.  
This protonation creates a hydrogen bonded enol, which is then capable of stabilizing the 
highly electron deficient cyclopentadiene.  For protonation at the Cp to occur, fewer 
electron-withdrawing groups are necessary.   
 




 We were also attracted to the Cp scaffold because of the wide array of chiral 
systems that have already been described in the literature.9  Three examples, shown in 
Figure 4, have been used in organometallic complexes for asymmetric reactions.  It might 
be possible with a chiral cyclopentadiene to induce asymmetry in the substitution step.  






























! pKa of cyanocyclopentadienes ! pentakis(methoxycarbonyl)cyclopentadiene
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 In 1965 Tsuji demonstrated that the allylpalladium chloride dimer was capable of 
undergoing displacement by soft nucleophiles, such as sodium diethylmalonate, to afford 
both mono- and diallylated malonates (Figure 5).10  This reaction was later confirmed by 
Trost in a publication where unsaturated hydrocarbons were treated with PdCl2 and 
Na2CO3 in DCM to generate π-allyl palladium chloride dimers in extremely high yields.  
Depending on the substrates, allylic isomers may be formed.11  Ultimately, these isomers 
could be treated with nucleophiles to afford allylated products.  These products were 
often found to be generated with complete regioselectivity and stereoselectivity.  In 1970, 
the catalytic version of this transformation was shown.12 Allylic alcohols and acetates 
























both carbon and nitrogen nucleophiles.  These publications opened the floodgates to the 
development of the widely used Tsuji–Trost reaction.   
 
Figure 5. First examples of allyl transfer  
 
  
 The Tsuji–Trost reaction has been extended to a wide array of allylic substrates 
and nucleophiles.  π-Allyl palladium species can be generated from allylic halides, 
carboxylates, carbonates, epoxides, and phosphates.  For chiral substrates, palladium 
insertion occurs on the reverse face of the leaving group (Figure 6).  Addition of 
nucleophiles occurs in two different mechanisms.  Soft nucleophiles, such as highly 
stabilized malonates or enamines, result in products with retention of stereochemistry.  
This stereoselectivity occurs by the nucleophile undergoing an SN2-like addition.  Hard 












































Instead of an SN2 pathway, the nucleophile first coordinates to the palladium center and 
then reductively eliminates to form the product.  
 
Figure 6. Tsuji–Trost allylation mechanism 
 
  
 Over the past few decades, the creation of chiral ligands have made it possible to 
perform the reaction in an asymmetric manner.13  Some of the most common ligands have 
been developed in the Trost group (Figure 7).  These C2-symmetric bisaminophosphines, 
based on such scaffolds as trans-diaminocyclohexane14 and ethanoanthracene,15 
coordinate to palladium in a bidentate fashion.  These ligands are now commercially 
available and are widely used in the synthetic community.  A multitude of other scaffolds 
have been developed; two other examples are shown below.  The Carretero group utilized 
a chiral 1-phosphino-2-sulfenylferrocene ligand in their version of the Tsuji-Trost 
allylation.16  Nucleophilic addition of the malonate is then favored to a single face of the 
chiral π-allyl palladium complex.  Both dimethyl malonate and benzylamine nucleophiles 
work in excellent yield and enantioselectivity.  The Stoltz group has used racemic allyl β-
ketoesters in their method to create chiral α-keto quaternary centers.17  For this reaction, 























enolate.  This enolate then serves as the nucleophile that attacks the preformed π-allyl 
palladium substrate.  Again, a chiral oxazoline ligand renders the reaction asymmetric.  
 
Figure 7. Asymmetric Tsuji–Trost allylation 
  
 
Development of a Cyclopentadienyl leaving group 
 
 We were intrigued by two reports of a carbon–carbon bond cleavage of allylic β-
dicarbonyl substrates by that action of Pd(0) (Figure 8).  In the first case from Cazes,18 









































(S,S)-DACH phenyl ligand (S,S)-ADEN phenyl ligand
! Asymmetric reactions
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Trost mechanism in which the β-ketoester acts as both the initial leaving group and then 
as the nucleophile.  This reaction was facilitated by the alkoxy substituent aiding in the 
carbon-carbon bond cleavage in an electronic push-pull system.  Similarly, Bäckvall19 has 
shown that bisallylic malonates are capable of isomerization through the same 
mechanism to afford the linear conjugated systems.  This reaction, however, requires 
prolonged heating and an external source of malonate anion.    
 
Figure 8. Isomerization of allylic β-dicarbonyls 
 
  
 With these two examples, we first looked at whether an allylic cyclopentadiene 
could be a competent substrate for a Tsuji–Trost allylation (Figure 9).  For this reaction to 
occur, we would need to investigate what substitution about the cyclopentadiene is 
























! Reversible allylation of allylic ethers
! Reversible allylation of bisallylic malonates
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Figure 9. Tsuji–Trost allylation of allylic cyclopentadienes 
 
  
 As mentioned earlier, electron–withdrawing groups might be necessary to 
stabilize the Cp anion, but too many groups may render the Cp anion too stable and 
unreactive.  As an alternative to electron withdrawing groups, we surmised that extended 
conjugation with appended aryl rings might aid in stabilization.  Examples of 
cyclopentadienes without electron withdrawing groups are shown in Figure 10.  As a 
comparison, the pKa is greatly influenced by the addition of phenyl groups.  From the 
parent cyclopentadiene (pKa = 18) the stability of the conjugate base can be greatly 
increased by adding two phenyl groups (pKa = 14.3) and ultimately to pKa = 12.5 with 
pentaphenylcyclopentadiene.20 
 
Figure 10. pKa of arylcyclopentadienes in DMSO 
 
 
 We suspected that pentasubstitution of the cyclopentadiene would be necessary to 
avoid unwanted rearrangements (Figure 11).  It is possible that thermal [1,5]-hydride 

























allyl group at an sp2 carbon.  Additionally, pentaphenylcyclopentadiene should alkylate 
exclusively at the Cp ring as opposed to the aryl groups to maintain aromaticity (compare 
to pentakis(carboxymethyl)cyclopentadiene, Table 1). 
 
Figure 11.  Substitution effects  
 
 
 The synthesis of pentaphenylcyclopentadiene begins with the aldol condensation 
of 1,3-diphenylacetone and benzil in refluxing ethanolic KOH to yield 2,3,4,5-
tetraphenylcyclopentadienone (Figure 12).21  Addition of phenylmagnesium bromide and 
reduction with LiAlH4 afforded pentaphenylcyclopentadiene 1 in high yield.  Treatment 
of cyclopentadiene 1 with n-BuLi in THF followed by the addition of allyl bromide 
afforded the allylated Cp 2 in excellent yields. Allylated cyclopentadiene 2 was then 
subjected to the sodium salt of diethyl methylmalonate in THF with 20 mol% Pd(PPh3)4 
at reflux.  To our dismay there was no reaction, and allylated Cp 2 was recovered.  This 











! [1,5]-hydride shifts render substrate inactive




parent cyclopentadienes, the values for arylated cyclopentadienes are much higher than 
those of common leaving groups (HBr = 0.9 in DMSO).  This implied that there possibly 
was not enough stability of the Cp nor was there the requisite bond polarization about the 
allyl–cyclopentadiene bond.   
 
Figure 12. Preparation of allyl pentaphenylcyclopentadienes 
  
 
 To circumvent this problem, we sought to further stabilize the Cp anion by 
appending electron-withdrawing groups about the phenyl rings.  Treatment of the 
pentaphenylcyclopentadiene 1 with excess acetyl chloride and aluminum trichloride in 





























! Preparation of pentaphenylcyclopentadiene 1














! Attempted reaction with Cp 2
1
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(Figure 13).22  It was immediately apparent that the corresponding Cp anion does indeed 
possess greater stability because deprotonation took place under the action of 
triethylamine, as opposed to n-BuLi for pentaphenylcyclopentadiene.  Addition of allyl 
bromide to the anion of 3 afforded the allylated substrate in excellent yield.  Finally, 
treatment of this substrate with 20 mol% Pd(PPh3)4 and diethyl methylmalonate in 
refluxing THF resulted in full conversion to the allylated malonate in only 15 minutes. 
 








































! Pd catalyzed C-C cleavage
! Preparation of acetylated Cp 3













 This result demonstrated the ability to cleave an sp3-sp3 carbon-carbon bond in a 
rapid fashion (compare to Figure 8).  We were curious about this increased stabilization 
of the Cp ring and looked at the pKa for insight.  Using 1H NMR spectroscopy analysis, it 
was determined that Cp 3 has a pKa = 7.26 in DMSO.  This value is comparable to other 
leaving groups utilized in the Tsuji–Trost reaction, such as acetate and trialkylammonium 
(pKa = 12.3 and 9.0 in DMSO, respectively).20  
 The catalyst loading was studied, and it was determined that the reaction again 
went to full conversion with 5 mol% Pd(PPh3)4 (entry 4), albeit with an extended time of 
90 minutes. (Table 2). In the absence of Pd(PPh3)4 (entry 5), the starting material does not 
convert, which suggests that a direct SN2 mechanism is not operative. 
 
Table 2. Catalyst loading  
 
  
 We then looked at various allylic moieties and nucleophiles in this reaction (Table 
3).  Allyl, methallyl, and cinnamyl substrates (entries 1-3) all participated well in high 
yields.  The crotyl substrate (entry 4) unfortunately did not react even after prolonged 




















































heating.  Crotonate ester substrate (entry 5) reacted efficiently without any side products 
arising from a conjugate addition.  A β-ketoester, ethyl methylacetoacetate (entry 6), 
could also serve as a competent nucleophile for the allylation.  We wondered if a Cp 
anion could act as the nucleophile and were delighted to find that the lithium salt of 
pentaphenylcyclopentadiene worked in high yield (entry 7).  This result parallels the pKa 
values of the Cp anions.  Lastly, we were excited to find that amine nucleophiles could be 
used (entry 8).  Using N-methylbenzylamine, Cs2CO3, and 50 mol% Pd(PPh3)4, we were 
able to obtain a 69% yield of the allylated amine. 
 
Table 3. Substrate scope 
 
  







































































 This last result was worthy of note because prolonged reaction times or higher 
temperature did not result in an increase in yield.  Additionally, the allylated Cp was not 
fully consumed.  We felt that the reaction with an amine may be an equilibrium mixture 
of both N- and C-allylated products.  Indeed, monitoring the reaction by 1H NMR showed 
only these two species.  To test the whether this reaction was in equilibrium, the reaction 
was run in reverse (Figure 14).  Thus, allylamine 5 and cyclopentadiene 3 were heated in 
the presence of Pd(PPh3)4 in THF.  After three hrs, a 69:31 mixture of allylamine 5 and 
allylated Cp 4 was observed, which is identical to the ratio observed in Table 3.  In this 
mechanism, allylated amine 5 and cyclopentadiene 3 first react as a Brønsted acid-base 
pair to form Cp anion 6 and ammonium ion 7.  Palladium then inserts into the allyl-
nitrogen bond to form palladium-π allyl species 8, which is able to undergo displacement 
by the Cp anion to form allylated Cp 4.  To confirm this mechanism, the Cp proton of 3 
was initially removed.  In this case, Cp anion 6 and allylamine 5 were mixed under the 
same conditions and resulted in no reaction.  Pd is unable to insert into the carbon–
nitrogen bond of the neutral amine 5 as it was able to with ammonium substrate 7.  This 









Figure 14. Mechanism of reversible amine allylation 
 
 
Efforts toward a direct SN2 reaction: 
 
 With the success of the palladium catalyzed Tsuji–Trost reaction, we were 
intrigued to find other conditions that might follow through a direct SN2 reaction.  Table 4 
shows a sample of reactions that were tried.  With the allylated 
pentaphenylcyclopentadiene, attempts were made using organometallic reagents, such as 
phenyllithium and both high and low order cuprates (entries 1-3), all with no success.  
Malonates and amines (entries 4-5) at elevated temperatures also gave no reaction.  





















































! Equilibrium of amine nucleophiles


















Cp complex did not result in carbon-carbon bond cleavage.  Again, we felt that the 
electronic properties might not be appropriate and looked at the allylated penta(4-
acetylphenyl)cyclopentadiene.  Addition of an array of Lewis acids (entry 7) to bind to 
the aryl ketones did not make the allyl moiety susceptible to displacement.  Finally, 
stabilized nitrogen sources, such as potassium phthalimide (entry 8) gave no reaction.  
This last result is due to the relative stability of the phthalimide anion compared to the 
penta(4-acetylphenyl)cyclopentadienyl anion. 
 
















































 We have demonstrated the ability to cleave the sp3–sp3 carbon-carbon bond of a 
substituted allylic cyclopentadiene by the action of Pd(PPh3)4.  The intermediate π-allyl 
palladium species can then be intercepted by stabilized carbon nucleophiles and also by 
amines.  The reaction with amines results in an equilibrium mixture of C– and N–
allylated species.  The reactivity and stability of the cyclopentadienes were explained by 
comparison of the relative pKa values.  Development of carbon-based nucleofuges has 
created a platform for further work in the area of substitution and elimination.  Future 
work will focus on the development of chiral analogs of cyclopentadienes, their use in 
asymmetric synthesis, and the development of a direct SN2 reaction. 
  108 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General Information.  All reactions were performed using oven-dried glassware under 
an atmosphere of dry argon.  Non-aqueous reagents were transferred by syringe under 
argon.  Organic solutions were concentrated using a Büchi rotary evaporator. 
Tetrahydrofuran was dried using a J.C. Meyer solvent purification system.  Triethylamine 
was freshly distilled over CaH2 under argon.  All other commercial reagents were used as 
provided.  Flash column chromatography was performed employing 32-63 μm silica gel 
(Dynamic Adsorbents Inc).  Thin-layer chromatography (TLC) was performed on silica 
gel 60 F254 plates (EMD). 
 1H and 13C NMR were recorded in CDCl3 on Bruker DRX-300 or DRX-400 
spectrometers as noted.  Data for 1H NMR are reported as follows: chemical shift (δ 
ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
integration, coupling constant (Hz), and assignment.  Data for 13C NMR are reported in 
terms of chemical shift. IR spectra were recorded on a Nicolet Avatar 370 DTGS 
(Thermo) using NaCl salt plates.  Low-resolution mass spectra (MS) were acquired on a 
JEOL JMS-LCmate liquid chromatography mass spectrometer system using CI+ 





diene2 were prepared according to known literature 
                                                 
1 Lowack, R. H.; Volhardt, K. P. C. J. Organomet. Chem. 1994, 476, 25-32. 
2 Martn-Matute, B.; Edin, M.; Bogr, K.; Kaynak, F. B.; Bäckvall, J.-E.; J. Am. Chem. 
Soc. 2005, 127, 8817-8825. 
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5-allyl-1,2,3,4,5-penta(4-acetylphenyl)cyclopentadiene (Table 3, substrate 1) –
Triethylamine (466 µL, 3.34 mmol) was added to a solution of 1,2,3,4,5-penta(4-
acetylphenyl)cyclopentadiene (2 g, 3.04 mmol) in THF (12 mL).  After stirring for 10 
min, allyl bromide (405 µL, 4.56 mmol) was added and allowed to stir for 18 hrs.  The 
solution was diluted with H2O (10 mL), 2 mL of 1 N HCl, and extracted into EtOAc (3 × 
10 mL).  The organics were dried over Na2SO4, concentrated, and purified by silica gel 
chromatography (50 to 60% EtOAc in hexanes) to afford the allylated product as a 
yellow solid (1.9 g, 2.73 mmol, 90%).  1H NMR (400 MHz, CDCl3) δ 7.89 (d, 2H, J = 8 
Hz, ArH), 7.67 (d, 4H, J = 8 Hz, ArH), 7.58 (d, 4H, J = 8 Hz, ArH), 7.39 (d, 2H, J = 8 
Hz), 7.01 (d, 4H, J = 8 Hz, ArH), 6.78 (d, 4H, J = 8 Hz, ArH), 5.71 (m, 1H, CH2CHCH2), 
5.13 (d, 1H, J = 10.4 Hz, CH2CHCH2), 5.02 (d, 1H, J = 16.8 Hz, CH2CHCH2), 3.07 (d, 
2H, 6 Hz, CH2CHCH2), 2.56 (s, 3H, C(O)CH3), 2.48 (s, 6H, C(O)CH3), 2.43 (s, 6H, 
C(O)CH3); 13C NMR (100 MHz, CDCl3) δ 197.32, 197.28, 197.19, 151.08, 144.61, 
143.64, 139.35, 139.26, 136.02, 135.75, 135.59, 131.45, 129.90, 129.39, 129.02, 128.02, 
127.82, 126.43, 118.92, 66.80, 34.71, 26.41, 26.36, 26.29; IR (thin film) 3074, 3003, 
2923, 1681, 1588, 1401, 1347, 1254 cm-1; LRMS (APCI+) exact mass calc’d for 











5-(2-methallyl)-1,2,3,4,5-penta(4-acetylphenyl)cyclopentadiene (Table 3, substrate 2) 
– Prepared using the general procedure above from triethylamine (116 µL, .84 mmol), 
1,2,3,4,5-penta(4-acetylphenyl)cyclopentadiene (500 mg, .76 mmol), THF (3 mL), and 3-
bromo-2-methylpropene (115 µL, 1.14 mmol).  The crude solid was purified via silica gel 
chromatography (50% EtOAc in hexanes) to afford the title product as a yellow solid 
(350 mg, .49 mmol, 65%).  1H NMR (400 MHz, CDCl3) δ 7.89 (d, 2H, J = 8.4 Hz, ArH), 
7.69 (d, 4H, J = 8 Hz, ArH), 7.59 (d, 4H, J = 8.4 Hz, ArH), 7.44 (d, 2H, J = 8.4 Hz, 
ArH), 7.0 (d, 4H, J = 8.4 Hz, ArH), 6.80 (d, 4H, J = 8.4 Hz, ArH), 4.80 (s, 1H, 
CH2C(CH3)CH2), 4.77 (s, 1H, CH2C(CH3)CH2), 3.10 (s, 2H, CH2C(CH3)CH2), 2.57 (s, 
3H, C(O)CH3), 2.50 (s, 6H, C(O)CH3), 2.45 (s, 6H, C(O)CH3), 1.68 (s, 3H, 
CH2C(CH3)CH2); 13C NMR (100 MHz, CDCl3) δ 197.9, 197.9, 197.7, 152.3, 145.5, 
144.9, 140.8, 140.0, 139.9, 136.5, 136.3, 136.1, 130.3, 130.0, 129.6, 128.7, 128.3, 126.5, 
113.2, 66.9, 38.2, 26.96, 26.92, 26.90, 25.5; IR (thin film) 306.5, 2998, 2909, 1677, 
1597, 1401, 1352, 1254, 1352, 1254, 1178, 1018, 960, 836 cm-1; LRMS (APCI+) exact 













5-crotyl-1,2,3,4,5-penta(4-acetylphenyl)cyclopentadiene (Table 3, substrate 4) – 
Prepared by the general procedure using triethylamine (116 µL, .84 mmol), 1,2,3,4,5-
penta(4-acetylphenyl)-cyclopentadiene (500 mg, .76 mmol), THF (2.5 mL), and E-crotyl 
bromide (117 µL, 1.14 mmol) The crude solid was purified via silica gel chromatography 
(50% EtOAc in hexanes) to afford the title product as a yellow solid (372 mg, .52 mmol, 
69%).  1H NMR (400 MHz, CDCl3) δ 7.88 (d, 2H, J = 8.4 Hz, ArH), 7.68 (d, 4H, J = 8 
Hz, ArH), 7.58 (d, 4H, J = 8.4 Hz, ArH), 7.38 (d, 2H, J = 8.4 Hz, ArH), 7.0 (d, 4H, J = 
8.4 Hz, ArH), 6.77 (d, 4H, J = 8.4 Hz, ArH), 5.37 (m, 2H, CH2CHCHCH3), 3.00 (m, 2H, 
CH2CHCHCH3), 2.56 (s, 3H, C(O)CH3), 2.49 (s, 6H, C(O)CH3), 2.44 (s, 6H, C(O)CH3), 
1.65 (m, 3H, CH2CHCHCH3); 13C NMR (100 MHz, CDCl3) δ 197.34, 197.32, 197.24, 
151.3, 144.6, 144.0, 139.6, 139.5, 136.0, 135.8, 135.6, 129.9, 129.5, 129.0, 128.1, 127.8, 
126.6, 123.6, 67.3, 67.0, 33.9, 26.44, 26.39, 26.33, 18.0; IR (thin film) 3052, 3002, 2909, 
1681, 1597, 1405, 1356, 1254, 1178, 960, 840 cm-1; LRMS (APCI+) exact mass calc’d 














5-cinnamyl-1,2,3,4,5-penta(4-acetylphenyl)cyclopentadiene (Table 3, substrate 3) – 
Prepared from the general procedure above from triethylamine (116 µL, .84 mmol), 
1,2,3,4,5-penta(4-acetylphenyl)-cyclopentadiene (500 mg, .76 mmol), THF (2 mL), and 
cinnamyl bromide (169 µL, 1.14 mmol).  The crude solid was purified via silica gel 
chromatography (50% EtOAc in hexanes) to afford the cinnamylated product as a yellow 
solid (500 mg, .65 mmol, 85%).  1H NMR (400 MHz, CDCl3) δ 7.94 (d, 2H, J = 8.4 Hz, 
ArH), 7.68 (d, 4H, J = 8 Hz, ArH), 7.61 (d, 4H, J = 8.4 Hz, ArH), 7.44 (d, 2H, J = 8.4 
Hz, ArH), 7.25 (m, 5H, ArH), 7.0 (d, 4H, J = 8.4 Hz, ArH), 6.82 (d, 4H, J = 8.4 Hz, 
ArH), 6.33 (d, 1H, J = 15.6 Hz, PhCHCHCH2), 6.11 (dt, 1H, J = 6.8, 15.6 Hz, 
PhCHCHCH2), 3.24 (d, 2H, 6.8 Hz, PhCHCHCH2), 2.60 (s, 3H, C(O)CH3), 2.49 (s, 6H, 
C(O)CH3), 2.45 (s, 6H, C(O)CH3); 13C NMR (100 MHz, CDCl3) δ 197.33, 197.28, 
197.22, 151.2, 144.8, 143.7, 139.4, 139.3, 136.9, 136.2, 135.8, 135.7, 133.8, 129.9, 129.5, 
129.1, 128.6, 128.1, 127.9, 127.5, 126.6, 125.8, 123.0, 67.4, 34.1, 26.5, 26.37, 26.32; IR 
(thin film) 3052, 3003, 2918, 1681, 1597, 1401, 1352, 1254, 1174, 1018, 956, 836 cm-1; 














(Table 3, substrate 5) – Prepared by the general procedure using triethylamine (71 µL, .46 
mmol), 1,2,3,4,5-penta(4-acetylphenyl)cyclopentadiene (300 mg, .51 mmol), THF (1.8 
mL), and methyl 4-bromocrotonate (81 µL, .69 mmol) The crude solid was purified via 
silica gel chromatography (50% EtOAc in hexanes) to afford the title product as a yellow 
solid (250 mg, .33 mmol, 72%).  1H NMR (400 MHz, CDCl3) δ 7.91 (d, 2H, J = 8 Hz, 
ArH), 7.69 (d, 4H, J = 8 Hz, ArH), 7.58 (d, 4H, J = 8 Hz, ArH), 7.38 (d, 2H, J = 8.4 Hz, 
ArH), 7.02 (d, 4H, J = 8 Hz, ArH), 6.83 (dt, 1H, J = 6.8, 15.6, CH2CHCHC(O)OCH3), 
6.74 (d, 4H, J = 8 Hz, ArH), 5.77 (d, 1H, CH2CHCHC(O)OCH3), 3.71 (s, 3H, 
CH2CHCHC(O)OCH3), 3.19 (d, 2H, CH2CHCHC(O)OCH3), 2.57 (s, 3H, C(O)CH3), 
2.48 (s, 6H, C(O)CH3), 2.43 (s, 6H, C(O)CH3); 13C NMR (100 MHz, CDCl3) δ 197.3, 
197.2, 197.1, 166.2, 150.4, 145.3, 142.9, 142.1, 139.0, 138.8, 136.3, 135.9, 135.8, 129.8, 
129.3, 129.2, 128.1, 127.9, 126.4, 124.3, 66.5, 51.5, 33.0, 26.41, 26.35, 26.29; IR (thin 
film) 3052, 3000, 2913, 1713, 1678, 1595, 1395, 1347, 1260 cm-1; LRMS (APCI+) exact 
















Diethyl 2-allyl-2-methylmalonate3 (Table 3, entry 1) – Diethyl methylmalonate (36 µL, 
.21 mmol) was added to a suspension of NaH (8.4 mg, .21 mmol, 60% in mineral oil) in 
THF (2 mL).  After stirring for 15 min, the solution was added to a solution of 5-allyl-
1,2,3,4,5-penta(4-acetylphenyl)cyclopentadiene (100 mg, .14 mmol) and Pd(PPh3)4 (8 
mg, .0007 mmol) in THF (3 mL) and heated to reflux for 1.5 hrs.  The reaction was 
cooled to room temperature and then diluted with dilute HCl.  The mixture was extracted 
into EtOAc, then briefly dried over Na2SO4 and concentrated in vacuo.  The crude 
mixture was then purified on a silica gel column (5% EtOAc in hexanes) to yield 
allylated malonate (24 mg, .11 mmol, 80%).  Increasing the polarity to 50% EtOAc in 
hexanes allowed for recovery of 1,2,3,4,5-pentakis(4-acetylphenyl)cyclopentadiene (80 
mg, .11 mmol, 86%).  1H NMR (300 MHz, CDCl3) δ 5.69 (m, 1H, CH2CHCH2C), 5.10 
(m, 2H, CH2CHCH2C), 4.17 (q, 4H, J = 7.2 Hz, CH3CH2O), 2.60 (d, 2H, J = 7.5 Hz, 





                                                 






Diethyl 2-(2-methallyl)-2-methylmalonate4 (Table 3, entry 2) – The title compound was 
prepared as above using 5-(2-methallyl)-1,2,3,4,5-penta(4-acetylphenyl)cyclopentadiene 
(90 mg, .13 mmol) and the reaction time was increased to 4 hrs to afford a colorless oil 
(20 mg, .09 mmol, 71%). 1H NMR (300 MHz, CDCl3) δ 4.85 (s, 1H, CCH2C(CH3)CH2), 
4.72 (s, 1H, CCH2C(CH3)CH2), 4.17 (q, 4H, J = 6.9 Hz, CH3CH2O), 2.68 (s, 2H, 
CCH2C(CH3)CH2), 1.65 (s, 3H, CCH2C(CH3)CH2), 1.39 (s, 3H, CCH3), 1.24 (t, 6H, J = 




Diethyl 2-cinnamyl-2-methylmalonate5 (Table 3, entry 3) – The title compound was 
prepared as above using 5-cinnamyl-1,2,3,4,5-penta(4-acetylphenyl)cyclopentadiene (108 
mg, .14 mmol) and the reaction time was increased to 4 hrs to afford a colorless oil (28.2 
mg, .097 mmol, 70%).  1H NMR (300 MHz, CDCl3) δ 7.3 (m, 5H, ArH), 6.45 (d, 1H, J = 
15.9 Hz, PhCHCHCH2), 6.11 (dt, 1H, J = 7.5, 15.6 Hz, PhCHCHCH2), 4.21 (q, 2H, J = 
                                                 
4 Veber, M.; Duong, K. N.-V.; Gaudemer, A.; Johnson, M. D. J. Organomet. Chem. 
1981, 209, 393-399. 
5 van Haaren, R.J.; Druijven, C. J. M.; van Strijdonck, G. P. F.; Oevering, H., Reek, J. N. 








7.5 Hz, CH3CH2O), 2.77 (d, 2H, J = 7.5 Hz, PhCHCHCH2), 1.43 (s, 3H, CH3C), 1.25 (t, 





Diethyl 2-(3-methoxycarbonyl-2-propenyl)-2-methylmalonate6 (Table 3, entry 5) – 
The title compound was prepared as above using 5-(3-carbomethoxy-2-propenyl)-
1,2,3,4,5-penta(4-acetylphenyl)cyclopentadiene (105 mg, .14 mmol) to afford a near 
colorless oil (27.2 mg,  .1 mmol, 71%). 1H NMR (300 MHz, CDCl3) δ 6.83 (dt, 1H, J = 
7.8, 15.6 Hz, CH2CHCHC(O)OCH3), 5.87 (d, 1H, J = 15.6 Hz, CH2CHCHC(O)OCH3), 
4.18 (q, 4H, J = 6.9 Hz, CH3CH2O), 3.71 (s, 3H, CH2CHCHC(O)OCH3), 2.73 (d, 2H, J = 







                                                 







Ethyl 2-Acetyl-2-methyl-4-pentenoate7 (Table 3, entry 6) – The title compound was 
prepared as above using ethyl 2-methylacetoacetate (30 µL, .21 mmol) as the nucleophile 
and 5-allyl-1,2,3,4,5-penta(4-acetylphenyl)cyclopentadiene (100 mg, .14 mmol) to yield 
an off-yellow oil (20 mg, .11 mmol, 78%).  1H NMR (300 MHz, CDCl3) δ 5.65 (m, 1H, 
CH2CHCH2C), 5.10 (m, 2H, CH2CHCH2C), 4.19 (q, 2H, J = 7.2 Hz, CH3CH2O), 2.63 
(dd, 1H, J = 7.2, 14.1 Hz, CH2CHCH2C), 2.49 (dd, 1H, J = 7.2, 14.1 Hz, CH2CHCH2C), 




5-allyl-1,2,3,4,5-pentaphenylcyclopentadiene (Table 3, entry 7)  – n-BuLi (44 µL, .11 
mmol) was added to a suspension of 1,2,3,4,5-pentaphenylcyclopentadiene (49 mg, .11 
mmol) in 1.5 mL of THF at 0 °C.  The white suspension slowly turned green and was 
allowed to stir for 10 min.  After this time, the solution was added to a solution of 5-allyl-
1,2,3,4,5-pentakis(4-acetylphenyl)cyclopentadiene (50 mg, .072 mmol) and Pd(PPh3)4 
(4.1 mg, .0036 mmol) in 1 mL THF.  The mixture was then heated to reflux for 3 hrs.  
Upon completion, the solution was diluted with H2O, 1 mL of 1 N HCl was added, and 
                                                 























extracted with EtOAc.  The organics were dried over Na2SO4 and concentrated.  The 
residue was purified by silica gel chromatography (1.5% EtOAc in hexanes) to yield the 
title product as a white solid (27 mg, .055 mmol, 77%).  1H NMR (400 MHz, CDCl3) δ 
7.33 (m, 2H, ArH), 7.24 (m, 2H, ArH), 7.18 (m, 1H, ArH), 7.04 – 6.93 (m, 16H, ArH), 
5.75 (m, 4H, ArH),  5.78 (m, 1H, CH2CHCH2C), 5.06 (d, 1H, J = 10.4 Hz, 
CH2CHCH2C), 5.00 (d, 1H, J = 17.2 Hz, CH2CHCH2C), 3.01 (d, 2H, J = 6.4 Hz, 
CH2CHCH2C); 13C NMR (100 MHz, CDCl3) δ 150.4, 144.3, 139.4, 135.86, 135.82, 
133.5, 130.1, 129.7, 128.6, 127.5, 127.4, 126.6, 126.5, 117.5, 66.2, 34.8; IR (thin film) 
3083, 2967, 1944, 1792, 1592, 1494, 1169, 1079, 1031, 907 cm-1; LRMS (APCI+) exact 





5-allyl-1,2,3,4,5-pentaphenylcyclopentadiene – n-BuLi (96 µL, .24 mmol, 2.5 M in 
hexanes) was added to a suspension of 1,2,3,4,5-pentaphenylcyclopentadiene (100 mg, 
.22 mmol) in THF (1 mL) at –78 °C.  The temperature was slowly raised to 0 °C and 
stirred an additional 10 min.  The solution was recooled to -78 °C, allyl bromide (29 µL, 
.33 mmol) was then added dropwise, and the temperature was allowed to reach 23 °C.  
After another 25 min, the reaction was quenched with water, extracted into EtOAc, dried 














chromatography (2.5% EtOAc in hexanes) to yield a white solid (100 mg, .21 mmol, 
93%).  Spectroscopic data matches the above data. 
 




(Table 1, entry 8) – 5-allyl-1,2,3,4,5-penta4-acetylphenyl)cyclopentadiene (20 mg, .029 
mmol), N-benzylmethylamine (3.7 µL, .029 mmol), Cs2CO3 (9.3 mg, .029 mmol), and 
Pd(PPh3)4 (16 mg, .014 mmol) were dissolved in THF (500 µL) in a sealed 2 dram vial 
under argon.  The reaction was heated to 70 °C for 3 hrs, then cooled to 23 °C, and 5 µL 
(.026 mmol) of benzyl ether was added as an internal standard.  An aliquot was taken out, 
concentrated, and analyzed by 1H NMR, which showed 69% N-benzyl-N-
allylmethylamine and 31% N-benzylmethylamine. For N-benzyl-N-allylmethylamine8 1H 
NMR (400 MHz, CDCl3) δ 7.28 (m, 5H, ArH), 5.91 (m, 1H, NCH2CHCH2), 5.18 (m, 
2H, NCH2CHCH2), 3.49 (s, 2H, CH2Ph), 3.03 (d, 2H, NCH2CHCH2), 2.19 (s, 3H, 
NCH3). 
 
                                                 





















(Figure 4) – 1,2,3,4,5-penta(4-acetylphenyl)cyclopentadiene (19 mg, .029 mmol), N-
benzyl-N-allylmethylamine (4.7 mg, .029 mmol), Cs2CO3 (9.3 mg, .029 mmol), and 
Pd(PPh3)4 (16 mg, .014 mmol) were dissolved in THF (500 µL) in a sealed 2 dram vial 
under argon.  The reaction was heated to 70 °C for 3 hrs, then cooled to 23 °C, and 5 µL 
(.026 mmol) of benzyl ether was added as an internal standard.  An aliquot was taken out, 
concentrated, and analyzed by 1H NMR, which showed 69% N-benzyl-N-












































































































Chapter 3  
Kinetic Resolution of Alcohols by Chlorodehydration: 
 Development of Chiral Cyclopropenones and Chiral Formamides 
 
 
 Chapter 2 described work centered about the stability of cyclopentadienyl anions 
and their use as nucleofuges in the Tsuji–Trost reaction.  The Lambert group has also 
focused much attention on the cyclopropenium cation as a promoter and catalyst for a 
number of dehydrative reactions.  The first publication reported the use of 1,1-dichloro-
2,3-diphenylcyclopropene as a chlorodehydration reagent (Figure 1).1  As an example, 
enantiopure (S)-1-phenylethanol was treated with an equimolar amount of 
dichlorocyclopropene in DCM at 23 °C.  After only ten minutes, (R)-1-chloro-1-
phenylethane was obtained in high yield and high optical purity, suggesting that an SN2 
mechanism was operative. This process is amenable to primary, secondary, and tertiary 
alcohols (through an SN1 mechanism).  The reaction paradigm has been extended to other 
dehydrative processes such as the formation of acid chlorides for the purposes of 
amidation.2  Additionally, the Beckmann rearrangement of oximes to the corresponding 
amide can be done with catalytic dichlorocyclopropene.3  Lastly, 1,5- and 1,6-diols 
undergo dehydrative cyclization to the corresponding tetrahydrofurans and 





Figure 1. Cyclopropenium promoted dehydrative processes 
 
 
 These reactions rely on the equilibrium between geminal disubstituted 
cyclopropenes and the dissociated cyclopropenium cation (Figure 2).  In the 
chlorodehydration reaction, dichlorocyclopropene 1 is in equilibrium with 
chlorocyclopropenium cation 2.  Coordination of an alcohol followed by chloride 



































! Chlorodehydration of alcohols
! Activation of carboxylic acids













Displacement of the cyclopropenium ether with chloride affords the alkyl chloride and 
cyclopropenone 6, which is recoverable and can be reused in subsequent reactions.   
 
Figure 2. Chlorodehydration mechanism 
 
  
 It is important to note that the initial dichlorocyclopropene, generated by the 
addition of thionyl chloride or oxalyl chloride to the parent cyclopropenone, also happens 
to be a product of the chlorodehydration.  A chlorodehydration mechanism involving 
catalytic cyclopropenone could be postulated, a mechanism of which is shown in Figure 
3.  The dichlorocyclopropene participates in the standard chlorodehydration reaction to 
yield the alkyl chloride and cyclopropenone.  Addition of oxalyl chloride regenerates the 





























in our laboratory and requires mild heat and slow addition of the oxalyl chloride for 
optimal results.5 
 
Figure 3. Catalytic chlorodehydration 
 
 
 With an efficient method for chlorination established, we wondered if a chiral 
cyclopropenone could effectively participate in the kinetic resolution of alcohols by 
chlorodehydration (Figure 4).  This process could be accomplished either with the 
cyclopropenone as a stoichiometric reagent or a catalyst.  Thus, a racemic alcohol and 
chiral cyclopropenone with oxalyl chloride would generate an alkyl chloride along with 






















Figure 4. Kinetic resolution of alcohols by chlorodehydration 
 
 
Known Methods for Enantioselective Chlorination 
 
 There is a small amount of literature pertaining to methods that generate chlorides 
in an asymmetric manner.  In addition to nucleophilic substitution (i.e., chloride 
displacement of a chiral mesylate), the two major classes are α-chlorination of carbonyls 
and enantioselective chlorination of olefins.  The first group relies on formation of a 
chiral enolate, enol, or enolate equivalent that then reacts with a chloride source.  
Selected examples are shown in Figure 5.  Using SOMO catalysis with chiral 
imidazolidinones, the MacMillan group has shown that aldehydes can be functionalized 
using LiCl as the chloride source to generate α-chloroaldehydes in excellent ee.6  
Through a ketene intermediate, acid chlorides can also be α-chlorinated by the action of 
catalytic O-benzoylquinine and a perchlorinated quinone with a basic  resin.7  Excellent 
enantioselectivities are achieved.  Lastly, oxindoles, when coordinated to a calcium 
VAPOL phosphate catalyst, generate an enol that is capable of chlorination with N-
chlorosuccinimide.8  This catalyst system has also been shown to effect an asymmetric 













Figure 5. α-Chlorination of carbonyls 
 
 
 During their studies of the total synthesis of (−)-napyradiomycin A1, the Snyder 
group needed to add chlorine to an isolated olefin with defined stereochemistry (Figure 
6).  Without any good methods previously known, they developed a system by which a 
borane complex of (S)-1,1'-biphenanthrene-2,2'-diol binds to their substrate and allows 
the olefin to react with Cl2 to generate the dichloride in excellent ee.9  Recently, the 
Nicolaou group reported a catalytic method to chlorinate allylic alcohols.10  Using 
(DHQ)2PHAL and a chlorinated hypervalent iodine reagent, they were able to add 



































up to 96% ee














! !-Chlorination of acid chlorides
! Asymmetric chlorination of oxindoles
up to 99% ee
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Figure 6. Chlorination of olefins 
 
 
 The above examples use an enolate or olefin as the nucleophilic partner in the 
chlorination reactions. The prevalence of alcohols and their ease of synthesis, we felt, 
makes them a good starting material for an asymmetric chlorination method.  If a chiral 
cyclopropenone can be developed, then our method should be invaluable to 































! Ligand–assisted asymmetric chlorination
! Catalytic asymmetric chlorination




Development of Chiral Cyclopropenones 
 
 In developing a proficient chiral cyclopropenone, we need to consider two factors: 
1) what substituents (R* groups) would be capable of inducing asymmetry, and 2) what is 
the mechanism by which asymmetry is induced. 
 In the process of developing the asymmetric chlorodehydration reaction, we 
studied three substitution patterns about the dichlorocyclopropene: diaryl-, arylamino-, 
and diamino-series (Figure 7).  Both the diaryl- and arylaminocyclopropenes react with 
alcohols to afford the chloride products, although the latter with a reduced reaction rate.  
The diamino substrate, however, failed to react.  This effect was primarily due to the 
increased stability of the cyclopropenium cation and the inability of the hydroxyl group 
to associate.  We centered our attention to the diaryl- and arylaminocyclopropenes as 
potential substrates. 
 
Figure 7. Stability of substituted cyclopropenium cations 
 
 
 There are two mechanisms we considered by which the chiral cyclopropenium 










enantiomer binds to the cyclopropenium cation aided by steric or electronic effects.  
Alternatively, both alcohol enantiomers could reversibly bind to the cyclopropenium 
cation and only one of the diastereomeric pairs chlorinates.  Ultimately, we wanted to 
know if alcohol exchange was possible (Figure 8).   
 
Figure 8. Alcohol Exchange 
 
 
To test which mechanism may be operative we conducted the following experiment: 2,3-
diphenylcyclopropenone was treated first treated with oxalyl chloride to generate the 
dichloride and then with one equivalent of 1-phenyl-2-propanol in CD3CN (Figure 9).  
After one hour, full conversion to the cyclopropenium ether was observed by 1H NMR 
spectroscopy.  No chlorination was seen with secondary alcohols at 23 °C.  Then, one 
equivalent of 2-octanol was added and a mixture of cyclopropenium ethers was observed, 
suggesting that alcohol exchange was possible.  Diarylcyclopropenone catalysts could 

















Figure 9. Reversibility of alcohol coordination to diarylcyclopropenes 
 
 
 A similar experiment was conducted with phenyl N,N-diisopropylamino-
cyclopropenone (Figure 10).  The dichloride was generated followed by the addition of 
cyclohexanol.  After one hour, conversion to the cyclopropenium ether was complete and 
one equivalent of 2-octanol was added.  No formation of the cyclopropenium ether 
derived from 2-octanol was observed, suggesting that the cyclopropenium ether was 
stable.  The reverse experiment was performed first using 2-octanol and then adding 
cyclohexanol.  In this case only the cyclopropenium ether with 2-octanol was observed.  
If using the arylaminocyclopropenone, the enantiodifferentiating step must occur in 
































Figure 10. Irreversibility of alcohol coordination to arylaminocyclopropenes 
 
 
Synthesis of arylaminocyclopropenones 
 
 The synthesis of arylaminocyclopropenones begins with commercially available 
tetrachlorocyclopropene (Figure 11).  Friedel-Crafts alkylation between an arene and 
trichlorocyclopropenium tetrachloroaluminate (generated from tetrachlorocyclopropene 










































! Alcohol exchange with arylaminocyclopropene




yield arylhydroxycyclopropenone.11  Formation of the chlorocyclopropenone with thionyl 
chloride and the addition of amine furnishes the arylaminocyclopropenone.   
 
Figure 11. Synthesis of arylaminocyclopropenones 
 
 
 With the route to arylaminocyclopropenones developed, we sought to create a 
small library of compounds, a sample of which are shown in Figure 12.  We looked at 
chiral amines based on amino acids (7-9) with differing aryl groups, C2-symmetric 
pyrrolidine (10), a dihydroimidazole (11), (–)-ephedrine (12), and (S)-α-
methylbenzylamine (13).   
 
























































10 11 12 13
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 We tested the chlorodehydration reaction with methyl mandelate as the substrate 
(Figure 13).  This substrate was chosen because the chloride enantiomers were separable 
by chiral HPLC.  The reaction was initially performed with 50 mol% cyclopropenone and 
oxalyl chloride.  While the conversions were often high (up to 46%), the enantiomeric 
excess was continually less than 10%.  We looked at using large chiral amines, such as 
Bis((S)-1-phenylethyl)amine, but hindered amines proved difficult to attach to the 
cyclopropenone. 
 
Figure 13. Chlorodehydration with chiral cyclopropenone 
 
 
 There are some concerns that could explain the low selectivity. While the chiral 
amine shields one quadrant about the cyclopropenium cation, the entire bottom face is 
open for attack by either alcohol enantiomer (Figure 14).  The chiral amine is pointing 
away from the carbon at which the alcohol binds to. The phenyl substituent on the 
cyclopropenium cation is offering little steric effect, and 4) there is bond rotation about 
the cyclopropenium-nitrogen bond possibly causing the chiral substituent to face away 













Figure 14. Rationale for poor enantioselectivity 
 
 
 As mentioned earlier, large amines were too hindered to react with the 
chlorocyclopropenone (refer to Figure 11), and cyclopropenones bearing a larger 
aromatic group, such as naphthalene and anthracene, were insoluble in most organic 
solvents.  Ultimately, we wanted to develop a system in which the chiral center(s) was 
close to the carbon atom to which the alcohol binds. 
 
Development of Chiral Formamides 
 
 We realized that amides show similar reactivity to aminocyclopropenones.  A 
major resonance structure of the cyclopropenone 14 resembles that of an amide 15 
(Figure 15).  Additionally, the cyclopropenone reacts with oxalyl chloride to form 
iminium 16, while the amide reacts to form an imidoyl chloride 17.  An 




















! Three dimensional structure of cyclopropenium
! Rotation about the cyclopropenium-nitrogen bond
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Figure 15. Comparison of aminocyclopropenones to amides 
 
 
 One of the major problems with the chiral cyclopropenones was the distance 
between the chiral amine and the carbon atom that bears the chlorine atom.  An amide 
would lessen that distance.  Also, we would be able to vary the both the nitrogen and 
carbonyl substituents during structure optimization.   
 Dimethylformamide (DMF) has been used with activating agents to transform 
alcohols into alkyl chlorides (Figure 16).  In the first example, a primary alcohol is 
reacted with the in situ–generated Vilsmeier reagent (from DMF and SOCl2) to yield the 
primary alkyl chloride in 89% yield.12  A similar reaction from the Danishefsky 
laboratory turns 3,5-dimethoxybenzyl alcohol into the corresponding chloride along with 
a Vilsmeier–Haack formylation in excellent yield.13 With the knowledge that formamides 
and activating agents (SOCl2, (COCl)2, and POCl3) can effect chlorodehydration, we 
























Figure 16. Imidoyl chlorides as chlorinating agents 
 
  
 The sole example of chiral formamide catalysts is from the Iseki group in their 
asymmetric allylation of aldehydes (Figure 17).14  In their reaction, the chiral formamide 
binds to the allyltrichlorosilane forming pentacoordinate silicon.   This binding makes the 
silicon more electrophilic and allows coordination of the aldehyde and subsequent allyl 
transfer to afford enantioenriched homoallylic alcohols.   
 
Figure 17. Chiral formamide in synthesis 
 
 
 The initial foray into chiral formamides began with substrates based on C2-
symmetric amines.  (S,S)-2,5-Diphenylpyrrolidine was heated to reflux in ethyl formate 
to reveal formamide 18 in quantitative yield (Figure 18).  The formamide was then tested 
in the chlorodehydration reaction.  To methyl mandelate was added 10 mol% of 



































resulting in methyl (R)-α-chlorophenylacetate with a 36% ee.  This corresponds to a 
selectivity factor of 2.5.  Using 5 mol% catalyst, the yield is slightly diminished, with a 
consistent selectivity factor.  The chlorooxalate was also obtained and will be discussed 
in subsequent sections. 
 
Figure 18. Chlorodehydration with chiral formamide 
 
 
 This promising result led us to synthesize more chiral formamides using different 
scaffolds.  With the ubiquity of amino acids, we sought their use as building blocks for 
the formamide catalysts.  Amino alcohols, both commercially available or by reduction of 
amino acids, were condensed with acetone in the presence of MgSO4 to afford the 
corresponding oxazolidine, which was then formylated using formic acetic anhydride and 
Et3N (Figure 19).15  Ethyl formate was not effective in the formylation of oxazolidines.   
 


















































 Utilizing this route to synthesize formamides, a series of dimethyl-substituted 
oxazolidines were prepared (Figure 20).  The chlorodehydration was run with 10 mol% 
catalyst with most of the catalysts generating chlorides with an enantiomeric excess 
between 35-44% and selectivity factors between 2-2.7.  Unfortunately, most formamides 
did not turn over.  Additionally, the size of the substituent on the chiral carbon sometimes 
had little effect.  This effect can be seen comparing (–)-ephedrine derived 19, (R)-
phenylglycine derived 20, and (S)-phenylalanine derived 21.   
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 The substitution about the N,O-acetal was also varied as shown in Figure 21.  The 
synthesis of these formamides was the same as the dimethyl series, but different ketones 
were used instead of acetone.  Comparing the phenylalanine derived formamides, there is 
an increase in selectivity going from the dimethyl to diethyl substrates (21 and 28).  
Increasing the size of the acetal substituent to di-n-propyl decreased selectivity (27).  
Highly hindered substrates (adamantanone, benzophenone, and pinacolone derived 33, 
34, and 35) resulted in no chloride products (refer to discussion about oxalate formation).  
It appears that while larger groups about the acetal increase the selectivity factor, there is 
















Figure 21.  Variation of acetal substitution 
 
 
Issues Concerning Oxalate Formation 
 
 To address the issues with substrates that do not chlorinate, formamides 33, 34, 
and 35, we looked at the 1H NMR spectroscopy for insight.  Formamides that yield 
chlorinated products show rotamers from the nitrogen–carbonyl bond.  The substrates 
that did not give chlorides show only one formamide hydrogen resonance.  This suggests 
that the intermediate imidoyl chloride is not being formed (Figure 22).  The mechanism 

























































































chlorooxalate 37.  Chloride then adds to the imidoyl carbon resulting in intermediate 38.  
For oxalate expulsion, the nitrogen lone pair must have appropriate overlap with the C-O 
σ*, which can be accomplished by bond rotation to intermediate 39.  Extrusion of the 
chlorooxalate reveals the imidoyl chloride.  If bond rotation is hindered, such as in 
formamides 33, 34, and 35, then the imidoyl chloride never forms.  
 
Figure 22. Mechanism of imidoyl chloride formation 
 
 
 The inhibition of bond rotation also might explain why a substantial amount of 
oxalate  (up to 30%) is found in all of these reactions.  For substrates that do form 
chloride, there must be competition between methyl mandelate reacting with imidoyl 
chlorooxalate 37 and imidoyl chloride 40.  Reactions performed in the absence of catalyst 
do not produce oxalate, suggesting that oxalate products are not formed by a background 
reaction. 
 It would be interesting to know if the oxalate products were formed with any 
enantioselectivity.  To examine the oxalate product, formamide 33 and 1-phenylethanol 
was used (Figure 23).  The oxalate product of methyl mandelate was inseparable by 
































mol% catalyst and 50 mol% oxalyl chloride and then with ethanol to form the mixed 
oxalate.  Alternatively, ethyl chlorooxoacetate was used in place of oxalyl chloride.  In 
both cases the oxalate was formed as a racemic mixture. 
 
Figure 23. Determination of oxalate enantiomeric excess 
 
 
 To decrease the amount of oxalate, we looked at changing the reaction 
temperature to force imidoyl chloride formation.  Temperatures between 0–40 °C were 
tested and the results are displayed in Table 1.  At 0 °C, the reaction does not proceed, 
forming neither chloride nor oxalate.  Temperature has a large effect on the reaction rate, 
slowing the reaction to eight hrs at 10 °C and increasing the rate to 15 minutes at 40 °C.  
Oxalate formation does decrease, suggesting that the imidoyl chloride is not fully formed 





































Table 1. Temperature screen 
 
 
Issues Concerning Catalyst Turnover 
 
 The other problem encountered with the oxazolidine formamides was with 
catalyst turnover.  The reaction generates an equivalent of HCl, which we believe may be 
protonating the oxazolidine, rendering it inactive.  The addition of base increases 
background oxalate formation. Formamide 18 (Figure 18) did show turnover, so we 
looked at developing new pyrrolidine based formamides. 
 The following pyrrolidine and menthylamine-based catalysts were tested and their 
use in chlorination is reported below (Figure 24).  The dibenzyl and diester catalysts, 41 
and 42, did not perform well, while diarylpyrrolidines 43 and 44 increased the selectivity 
factor from 2.5 for diphenylpyrroldine 18 to 3.1 and 2.8 for 43 and 44, respectively.  
While para substitution has an effect, it is not apparent whether it is a steric or electronic 

















































 As with the chiral cyclopropenones, we were curious to know from where the 
selectivity of the formamides was derived.  In one situation, enantioselectivity is a result 
from the initial approach of the alcohol and imidoyl chloride, which was the case with the 
cyclopropenones.  Alternatively, both alcohol enantiomers can combine with the imidoyl 
chloride to make diastereomeric imidoyl ethers (Figure 25).  The alcohol portion would 
then be able to exchange with exogenous alcohol establishing an equilibrium.  One of 
these diastereomers would react with chloride to produce the enantioenriched chlorinated 






























































dineopentyl acetal of DMF, addition of 4-methoxybenzyl alcohol and a carboxylic acid 
resulted in formation of the imidoyl ether of the benzyl alcohol.   
 
Figure 25. Exchange of alcohols 
 
 
 A similar experiment to the one with the cyclopropenones in Figure 9 was run 
(Figure 26).  Formamide 18 was treated with oxalyl chloride to generate imidoyl chloride 
47.  Addition of 1-phenyl-2-propanol resulted in imidoyl ether 48 formation.  At 23 °C, 
chlorination of secondary alcohols does not occur.  Due to overlap in 1H NMR spectra, 
we were unable to observe distinct imidoyl ether resonances for each alcohol.  Therefore, 
we decided to use an alcohol capable of chlorination as the second alcohol.  If the 
corresponding chloride was produced, then we can infer that the alcohols did indeed 
exchange.  Thus, benzyl alcohol was added to the imidoyl ether and no change by 1H 
NMR spectroscopy was observed.  Benzyl chloride was not obtained, nor did imidoyl 
ether 48 change in intensity.  This result suggests that as with the cyclopropenones, 






















may be possible that exchange occurs, but is diminished because the formamides are 
highly hindered compared to DMF, as the Eschenmoser example showed. 
 
Figure 26. Testing exchange in formamide catalysts 
  
 
Proposed Transition State 
 
 It is interesting that diphenylpyrroldine formamide 18 and phenylglycine–derived 
amide 20 give opposite enantioselectivity even though the structures are similar.  With 
the assumption that the alcohol approaches the imidoyl chloride from the least hindered 
face, then we can propose that the largest group (phenyl) will be directed away from the 
oxazolidine placing the smallest group (hydrogen) toward the angular methyl (TS1a, 
Figure 27).  In addition to steric minimization, there may be an electronic effect between 
the electronegative chlorine and the δ+ charge of the ester carbonyl (TS1b).  This effect 
































not observed not observed
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Figure 27. Proposed oxazolidine 20 transition state 
 
 
 Using the same analysis on diarylpyrrolidine 18 with (S)-methyl mandelate, 
placing the largest substituent away from the pyrrolidine directs the ester within 
proximity of the angular phenyl, which would result in an unfavorable interaction (TS2 
Figure 28). The assumption that steric effects are the sole determining interactions is 
incorrect for pyrrolidine formamides.  If electronic effects exist, then a favorable 
electronic interaction between the ester and chlorine could occur along with a π-π 
interaction between the phenyl groups (TS3).  Further investigation would be necessary 
to determine what transition state is correct. 
 

















































 One method to test whether a π interaction exists is to change the electronic 
properties of the arenes and look for changes in reactivity.  To this end, pyrrolidine 58 
was chosen as a late stage derivitization substrate to introduce new functionality (Figure 
29).  The aryl bromide can be manipulated through metal–catalyzed reactions to yield 
new catalysts.  Pyrrolidine 58 was transformed to the aryl nitrile through palladium–
catalyzed cyanation to yield pyrrolidine 59.  Treatment with ethyl formate revealed the 
formamide catalyst in excellent yield.  
 
Figure 29. Derivitization of dibromoarylpyrrolidine 
 
 
 Formamide 59 was reacted under the chlorodehydration conditions and resulted in 
no reaction occurring, even at elevated temperature.  This result is not conclusive, 
because a range of electronically different formamides would need to be tested, but it 
does suggest that the electronic properties of the catalyst have an influence on reactivity.  
Using the same strategy, we would like to synthesize pyrrolidines with differing 
electronic and steric properties.  We are currently studying the synthesis of pyrrolidine 61 
to introduce substitution at the meta positions to yield pyrrolidine 62 (Figure 30).  This 
route offers the ability to diversify the electronic and steric properties at a later stage of 









R = H, 59









Figure 30. Meta substitution 
 
 
General formamide catalysis 
 
 Formamides have been an underutilized class of molecules with great potential to 
chemical synthesis.  Although formamides were initially developed in our laboratory for 
the purpose of asymmetric chlorodehydration, we plan to study their utility in other 
substitution reactions.  Ultimately an efficient substitution reaction will be developed 
(Figure 31).   
 
Figure 31. Substitution with formamide catalyst 
 
 
 Two areas of current research focus on formamide activating agents and 
formamide–catalyzed reactions.  Our attention was piqued by two reports using DMF and 
acid chlorides.  The first is a chlorodehydration reaction, akin to ours, in which an acid 
chloride is used to chlorodehydrate primary and secondary alcohols with good to high 

























In another report, DMF and benzoyl chloride were premixed to form a stable imidoyl 
benzoate 50.18  Addition of an alcohol reveals imidoyl ether 51, which is often isolable 
and stable under anhydrous conditions.  Acidic conditions cleave the iminium cation to 
form formate ester 52 and represents a mild method for the formylation of alcohols.   
 
Figure 32. Activation of DMF by acid chlorides 
 
  
 Imidoyl benzoate 50 is an interesting intermediate that we felt could change the 
selectivity in our formamide catalysts.   The carboxylate should change the steric and 
electronic environment about the catalyst.   Benzoyl chloride was used in place of oxalyl 
chloride in the chlorodehydration, but no reaction was observed.  It is possible that the 
steric environment is too crowded and does not allow for addition of an alcohol.  We are 
currently studying chiral formamides with small directing groups, such as 




























! Pivaloyl chloride activation




33).  An imidoyl ester, or other activated imidoyl species, would also allow us to study 
reactions other than chlorination. 
 
Figure 33. Activation of small formamides 
 
 
 In developing non-chlorination dehydration reactions, we again were inspired by 
the Eschenmoser report that DMF acetals undergo alcohol exchange with the addition of 
an alcohol and carboxylic acid (Figure 25).  In this paper, heating a mixture of DMF 
dimethyl acetal with (S)-2-butanol resulted in the acetal 55 (Figure 34).  Treatment with 
benzoic acid and heating to 80 °C collapsed acetal 55 to imidoyl ether 56, which was 
subsequently displaced by benzoate to yield the inverted ester 57.   In another example, 
the dineopentyl acetal of DMF 58 was treated with 4-methoxybenzyl alcohol and a 
protected phenylalanine.  The carboxylic acid serves fist as a proton source to collapse 
the acetal and allow for alcohol exchange to occur, revealing intermediate ion pair 59.  At 
room temperature, nucleophilic displacement occurs to form ester 60 and DMF.  Current 
work is underway to find alternative activating agents to obtain imidoyl ethers.  






















 This chapter describes the development of chiral cyclopropenones and chiral 
formamides for the purposes of kinetic resolution by chlorodehydration.  It was found 
that chiral cyclopropenones were incapable of inducing asymmetry, most likely due to 
the low proximity between the reactive site and chiral amine.  Transitioning to chiral 
formamides allowed for increased enantioselectivities and selectivity factors around 3.  
























































foundation for the process has been developed.   We are also studying acid chlorides as 
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General Information.  All reactions were performed using oven-dried glassware under 
an atmosphere of dry argon.  Non-aqueous reagents were transferred by syringe under 
argon.  Organic solutions were concentrated using a Büchi rotary evaporator. Diethyl 
ether, tetrahydrofuran, benzene, toluene, and methylene chloride (DCM) were dried using 
a J.C. Meyer solvent purification system.  Triethylamine and N,N-diisopropylethylamine 
were freshly distilled over CaH2 under argon.  All other commercial reagents were used 
as provided.  Flash column chromatography was performed employing 32-63 μm silica 
gel (Dynamic Adsorbents Inc).  Thin-layer chromatography (TLC) was performed on 
silica gel 60 F254 plates (EMD). 
 1H and 13C NMR were recorded in CDCl3 on Bruker DRX-300, DRX-400, or 
DRX-500 spectrometers as noted.  Data for 1H NMR are reported as follows: chemical 
shift (δ ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
integration, coupling constant (Hz), and assignment.  Data for 13C NMR are reported in 












Phenylhydroxycyclopropenone1: Tetrachlorocyclopropene (1.5 mL, 12.23 mmol) was 
added dropwise to a suspension of AlCl3 (1.58 g, 11.4 mmol) in DCM (25 mL) at 0 °C.  
After mixing for 10 min, a solution of benzene (980 µL, 10.9 mmol) in DCM (25 mL) 
was added over 5 min, then warmed to 23 °C and stirred overnight.  The reaction was 
then poured over crushed ice to destroy any remaining AlCl3. The organic layer was 
separated, dried over Na2SO4, and concentrated.  The residue was then diluted in acetone 
(50 mL) and ice water (15 mL) was introduced.  The resulting solution was mixed for 2.5 
hrs after which time the suspension was concentrated, filtered, and washed with water.  
The solid was dried under high vacuum to afford the hydroxycyclopropenone (1.4g, 9.6 
mmol, 87%). 
 
General synthesis of arylaminocyclopropenones:  Thionyl chloride (2 mL/mmol 
hydroxycyclopropeneone) was added slowly to a mixture of arylhydroxycyclopropenone 
(1 eq.) and 1 drop of DMF at 0 °C.  The reaction was allowed to warm to 23 °C over 30 
min.  At this point the reaction was concentrated, diluted in DCM (2 mL/mmol 
hydroxycyclopropenone), and a mixture of chiral amine (1 eq.) and N,N-
diisopropylethylamine (1.1 eq) in DCM (2 mL/mmol hydroxycyclopropenone) was 
added.  After stirring for 1 hr, the solution was washed with 1 N HCl (2 mL/mmol 




via silica gel chromatography (40 to 50% EtOAc in hexanes) to furnish the desired 




(7): Using the general synthesis, phenylhydroxycyclopropenone (75 mg, 0.51 mmol) and 
(R)-methyl N-isopropylphenylglycine (116 mg, 0.56 mmol) afforded the title 
cyclopropenone (63 mg, 0.19 mmol, 37%).  1H NMR (300 MHz, CDCl3) δ 7.39 (m, 10H, 
aryl), 5.75 (s, 1H, CHCO2Me), 3.83 (s, 3H, OCH3), 3.69 (m, 1H, CH(CH3)2), 1.48 (d, 3H, 




(S)-methyl 2-(benzyl(3-oxo-2-phenylcycloprop-1-enyl)amino)-3-methylbutanoate (8): 
Using the general procedure phenylhydroxycyclopropenone (75 mg, 0.51 mmol) and 
methyl N-benzyl valine (112 mg, 0.51 mmol) afforded the title cyclopropenone (70 mg, 
0.20 mmol, 39%).  1H NMR (300 MHz, CDCl3) δ 7.59 (m, 2H, aryl), 7.35 (m, 8H, aryl), 
4.83 (d, 1H, J = 15 Hz, benzylic), 4.70 (d, 1H, J = 15 Hz, benzylic), 3.58 (s, 3H, OCH3), 












CH(CH3)2), 0.91 (d, 3H, J = 6.6 Hz, CH(CH3)2); 13C NMR (75 MHz, CDCl3) δ 171.0, 
145.1, 143.7, 134.9, 129.5, 129.4, 129.0, 128.5, 128.1, 124.2, 113.0, 70.5, 58.2, 52.1, 





amino)-2-phenylethanoate (9): Using the general synthesis, 2-bromo-4-methoxyphenyl 
hydroxycyclopropeneone2 (130 mg, 0.51 mmol) and (R)-methyl N-isopropylphenyl-
glycine (116 mg, 0.56 mmol) afforded the title cyclopropenone (113 mg, 0.25 mmol, 
50%).  1H NMR (300 MHz, CDCl3) δ 7.37-7.11 (m, 7H, aryl), 6.78 (m, 1H, aryl), 5.71 (s, 
1H, CHCO2Me), 3.82 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 3.80-3.77 (m, 1H, CH(CH3)2), 
1.49 (m, 3H, CH(CH3)2), 1.05 (m, 3H, CH(CH3)2); 13C NMR (75 MHz, CDCl3) δ 170.1, 
160.4, 144.9, 142.9, 130.9, 130.7, 129.0, 128.9, 128.5, 128.2, 125.4, 124.7, 118.3, 113.5, 
















2-((2S,5S)-2,5-diphenylpyrrolidin-1-yl)-3-phenylcycloprop-2-enone (10): Using the 
general procedure phenylhydroxycyclopropenone (75 mg, 0.51 mmol) and (S,S)-2,5-
diphenylpyrrolidine3 (114 mg, 0.51 mmol) afforded the title cyclopropenone (100 mg, 
0.28 mmol, 56%).  1H NMR (300 MHz, CDCl3) δ 7.3 (m, 10H, aryl) 7.12 (m, 3H, aryl), 
7.01 (m, 2H, aryl), 5.44 (m, 2H, NCH), 2.66 (m, 1H, CH2), 2.50 (m, 1H, CH2), 2.05 (m, 
2H, CH2); 13C NMR (75 MHz, CDCl3) δ 146.1, 141.5, 141.4, 140.3, 129.0, 128.8, 128.6, 





Diphenylethylenediamine (213 mg, 1 mmol) was added to a solution of propionaldehyde 
(72 µL, 1 mmol) in DCM (10 mL) at 0 °C.  After 30 min, N-bromosuccinimide (186 mg, 
1.05 mmol) was added and the solution was left to stir at 23 °C overnight.  The reaction 
                                                        
3 Chong, J. .; Clarke, I. S.; Koch, I.; Olbach, P. C.; Taylor, N. J. Tetrahedron: Asymmetry, 
1995, 6, 409-418. 










was diluted with 1 N NaOH, extracted into DCM, dried over Na2SO4, and concentrated.  
The residue was dissolved into EtOAc, extracted into 1 N HCl, then made basic with 2 N 
NaOH.  The product was extracted into DCM, dried over Na2SO4, and concentrated to 
yield the amine (220 mg, 0.88 mmol, 88%).  1H NMR (300 MHz, CDCl3) δ 7.38 (m, 6H, 
aryl), 7.15 (t, 2H, J = 7.5 Hz, aryl), 7.04 (d, 2H, J = 7.2 Hz, aryl), 5.14 (d, 1H, J = 6 Hz, 
benzylic), 5.09 (d, 1H, J = 6 Hz, benzylic), 3.04 (q, 2H, J = 7.5 Hz, CH2CH3), 1.52 (t, 2H, 





enone (11):  Using the general procedure phenylhydroxycyclopropenone (50 mg, 0.34 
mmol) and (4S,5S)-2-ethyl-4,5-diphenyl-4,5-dihydro-1H-imidazole (85 mg, 0.34 mmol) 
afforded the title cyclopropenone (86 mg, 0.23 mmol, 67%).  1H NMR (300 MHz, 
CDCl3) δ 7.35 (m, 11H, aryl), 7.15 (t, 2H, J = 7.5 Hz, aryl), 7.04 (d, 2H, J = 7.2 Hz, aryl), 
5.14 (d, 1H, J = 6 Hz, benzylic), 5.09 (d, 1H, J = 6 Hz, benzylic), 3.04 (q, 2H, J = 7.2 Hz, 
CH2CH3), 1.52 (t, 3H, J = 7.2 Hz, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 163.5, 141.3, 
139.3, 135.2, 130.3, 129.6, 129.4, 129.0, 128.8, 128.6, 128.1, 126.3, 125.5, 122.8, 80.1, 












enone (12): Using the general procedure phenylhydroxycyclopropenone (100 mg, 0.68 
mmol) and  (–)-O-methyl ephedrine5 (244 mg, 0.68 mmol) afforded the title 
cyclopropenone (145 mg, 0.47 mmol, 69%).  1H NMR (300 MHz, CDCl3) δ 7.53 (m, 2H, 
aryl), 7.34 (m, 8H, aryl), 4.23 (d, 1H, J = 7.5 Hz, MeOCH), 3.42 (dq, 1H, J = 7.5, 6.9 Hz, 
NCH), 3.25 (s, 3H, OCH3), 2.95 (s, 3H, NCH3), 1.52 (d, 3H, J = 6.9 Hz, CHCH3); 13C 
NMR (75 MHz, CDCl3) δ 145.5, 142.9, 138.8, 128.9, 128.8, 128.4, 128.2, 127.2, 126.9, 





(S)-2-(methyl(1-phenylethyl)amino)-3-phenylcycloprop-2-enone (13): Using the 
general procedure phenylhydroxycyclopropenone (100 mg, 0.68 mmol) and (S)-N-
methyl-α-methylbenzylamine (92 mg, 0.68 mmol) afforded the title cyclopropenone (130 
mg, 0.49 mmol, 73%).  1H NMR (300 MHz, CDCl3) δ 7.62 (m, 2H, aryl), 7.34 (m, 8H,                                                         













aryl), 4.48 (q, 1H, J = 6.9 Hz, benzylic), 3.20 (s, 3H, NCH3), 1.80 (d, 3H, J = 6.9 Hz, 
CHCH3); 13C NMR (75 MHz, CDCl3) δ 144.8, 142.9, 140.8, 129.0, 128.8, 128.5, 128.0, 
126.7, 126.3, 124.3, 111.3, 63.3, 38.7, 20.9. 
 
General chlorination procedure with cyclopropenones:  To a solution of 
cyclopropenone (0.03 mmol) in MeCN-d3 (600 µL) was added oxalyl chloride (0.03 
mmol).  After 30 minutes, effervescence had ceased and methyl mandelate (0.6 mmol) 
was added.  After stirring overnight, the solution was concentrated, and purified by silica 




(2S,5S)-2,5-diphenylpyrrolidine-1-carbaldehyde (18):6 (S,S)-2,5-diphenylpyrrolidine 
(100 mg, 0.45 mmol) was heated with ethyl formate (1 mL) in a sealed vial to 57 °C for 
24 hrs.  The solution was concentrated and yielded pure product (113 mg, 0.45 mmol, 
quantitative). 1H NMR (300 MHz, CDCl3) δ 8.20 (s, 1H, CHO), 7.31 (m, 10H, aryl), 
5.40 (m, 1H, benzylic), 5.18 (m, 1H, benzylic), 2.48 (m, 2H, CH2CH2), 1.89 (m, 2H, 
CH2CH2).  Spectrum matched literature. 
 







(4R,5S)-2,2,4-trimethyl-5-phenyloxazolidine-3-carbaldehyde (19): (–)-Ephedrine (63 
mg, 0.52 mmol) was dissolved in acetone (1 mL) and MgSO4 (100 mg).  After 2 hrs, the 
solution was filtered and concentrated. Meanwhile, acetyl chloride (43 µL, 0.6 mmol) 
and 98% formic acid (24 µL, 0.62 mmol) were cooled in EtOAc (1.1 mL) to –78 °C.  
Et3N (181 µL, 1.30 mmol) was then added dropwise and stirred for 5 min.  A solution of 
the oxazolidine in EtOAc (500 µL) was added and the reaction was allowed to stir 
overnight.  The suspension was then filtered through Celite and rinsed with EtOAc.  Then 
the organic solution was washed with sat. NaHCO3, dried over Na2SO4, and concentrated.  
The residue was purified by silica gel chromatography (40% EtOAc in hexanes) to yield 
the title compound (77 mg, 0.35 mmol, 68%).  1H NMR (300 MHz, CDCl3) δ 8.33 (s, 
0.33H, CHO), 8.26 (s, 0.67H, CHO), 7.34 (m, 5H, aryl), 5.29 (d, 0.33H, J = 5.4 Hz, 
benzylic), 5.22 (d, 0.67H, J = 5.7 Hz, benzylic), 4.47 (apparent pentet, 0.67H, J = 6.3 Hz, 
CHN), 4.15 (m, 0.33H, CHN), 1.79 (s, 1.4H, CCH3), 1.72 (s, 2H, CCH3), 1.70 (s, 1.4H, 
CCH3), 1.61 (s, 2H, CCH3), 0.88 (d, 1H, J = 6.6 Hz, CHCH3), 0.83 (d, 2H, J = 6.6 Hz, 
CHCH3); 13C NMR (75 MHz, CDCl3) δ 158.5, 157.9, 135.8, 135.7, 128.3, 127.9, 127.8, 












(R)-4-phenyl-2,2-dimethyloxazolidine-3-carbaldehyde (20): (R)-Phenylglycinol (500 
mg, 1.46 mmol), MgSO4 (1.3 g), and acetone (2.7 mL) were stirred for 2 hrs. The 
reaction was filtered through Celite, rinsed with acetone, and concentrated.  Meanwhile, 
acetyl chloride (298 µL, 4.19 mmol) and 98% formic acid (165 µL, 4.37 mmol) were 
cooled in EtOAc (8 mL) to –78 °C.  Et3N (1.27 mL, 9.1 mmol) was then added dropwise 
and stirred for 5 min.  A solution of the oxazolidine in EtOAc (4 mL) was added and the 
reaction was allowed to stir overnight.  The suspension was then filtered through Celite 
and rinsed with EtOAc.  Then the organic solution was washed with sat. NaHCO3, dried 
over Na2SO4, and concentrated.  The residue was purified by silica gel chromatography 
(40 to 50% EtOAc in hexanes) to yield the title compound (590 mg, 2.87 mmol, 79%).  
1H NMR (300 MHz, CDCl3) δ 8.32 (s, 0.5H, CHO), 8.05 (s, 0,5H, CHO), 7.30 (m, 5H, 
aryl), 5.11 (dd, 0.5H, J = 6.9, 3.3 Hz, benzylic), 4.87 (apparent triplet, 0.5 H, J = 6.0 Hz, 
benzylic), 4.30 (m, 1H, OCH2), 3.99 (dd, 0.5H, J = 9.3, 3.6 Hz, OCH2), 3.90 (dd, 0.5H, J 
= 9.0, 5.4 Hz, OCH2), 1.77 (s, 1.5H, CH3), 1.66 (s, 3H, CH3), 1.57 (s, 1.5H, CH3); 13C 
NMR (75 MHz, CDCl3) δ 159.4, 158.0, 139.5, 139.0, 128.8, 128.3, 128.1, 127.2, 126.6, 








(S)-4-benzyl-2,2-dimethyloxazolidine-3-carbaldehyde (21): (S)-phenylalaninol (500 
mg, 3.31 mmol) was dissolved in acetone (2.4 mL) and MgSO4 (398 mg).  After 3 hrs, 
the solution was filtered and concentrated. Meanwhile, acetyl chloride (270 µL, 3.81 
mmol) and 98% formic acid (150 µL, 3.97 mmol) were cooled in EtOAc (8 mL) to –78 
°C.  Et3N (1.15 mL, 8.27 mmol) was then added dropwise and stirred for 5 min.  A 
solution of the oxazolidine in EtOAc (4 mL) was added and the reaction was allowed to 
stir overnight.  The suspension was then filtered through Celite and rinsed with EtOAc.  
Then the organic solution was washed with sat. NaHCO3, dried over Na2SO4, and 
concentrated.  The residue was purified by silica gel chromatography (50% EtOAc in 
hexanes) to yield the title compound (400 mg, 1.82 mmol, 55%).  1H NMR (300 MHz, 
CDCl3) δ 8.29 (s, 0.65H, CHO), 7.86 (s, 0.35H, CHO), 7.28 (m, 5H, aryl), 4.37 (m, 
0.73H), 3.97 (m, 0.72H), 3.86 (m, 2H), 3.31 (dd, 0.75H, J = 13.2, 3.3 Hz), 2.92 (d, 0.8H, 
J = 7.2 Hz), 2.68 (dd, 0.77H, J = 13.2, 10.5 Hz) 1.71 (s, 1.3H, CH3), 1.55 (s, 1.3H, CH3), 
1.52 (s, 2H, CH3), 1.49 (s, 2H, CH3); 13C NMR (75 MHz, CDCl3) δ 158.6, 158.1, 137.5, 
136.6, 129.3, 129.2, 1289.7, 128.4, 126.9, 126.5, 94.2, 92.5, 67.5, 66.6, 58.6, 56.5, 41.8, 




(S)-4-isopropyl-2,2-dimethyloxazolidine-3-carbaldehyde (22): (S)-Valinol (144 mg, 





was filtered through Celite, rinsed with acetone, and concentrated.  Meanwhile, acetyl 
chloride (114 µL, 1.61 mmol) and 98% formic acid (64 µL, 1.68 mmol) were cooled in 
EtOAc (3 mL) to –78 °C.  Et3N (488 µL, 9.1 mmol) was then added dropwise and stirred 
for 5 min.  A solution of the oxazolidine in EtOAc (1.5 mL) was added and the reaction 
was allowed to stir overnight.  The suspension was then filtered through Celite and rinsed 
with EtOAc.  Then the organic solution was washed with sat. NaHCO3, dried over 
Na2SO4, and concentrated.  The residue was purified by silica gel chromatography (50% 
EtOAc in hexanes) to yield the title compound (175 mg, 1.02 mmol, 70%).  1H NMR 
(300 MHz, CDCl3) δ 8.29 (s, 0.5H, CHO), 8.27 (s, 0,5H, CHO), 3.91 (m, 2.5H, NCH, 
CHO), 3.57 (dd, 0.5H, J = 7.2, 1.8 Hz, OCH2), 2.26 (m, 0.5H, CH(CH3)2), 1.91 (m, 0.5H, 
CH(CH3)2), 1.63 (s, 1.5H, CH3), 1.58 (s, 1.5H, CH3), 1.56 (s, 1.5H, CH3), 1.49 (s, 1.5H, 
CH3), 0.95 (m, 6H, CH(CH3)2); 13C NMR (75 MHz, CDCl3) δ 159.4, 159.0, 65.7, 64.9, 




2-aminoindanol formamide (23): (1R,2S)-2-amino-2,3-dihydro-1H-inden-1-ol7 (100 
mg, 0.67 mmol) was dissolved in acetone (2 mL) and a small scoop of MgSO4.  After 2.5 
hrs, the solution was filtered and concentrated. Meanwhile, acetyl chloride (55 µL, 0.77 




mmol) and 98% formic acid (30 µL, 0.8 mmol) were cooled in EtOAc (1.4 mL) to –78 
°C.  Et3N (233 µL, 1.68 mmol) was then added dropwise and stirred for 5 min.  A 
solution of the oxazolidine in EtOAc (400 µL) was added and the reaction was allowed to 
stir overnight.  The suspension was then filtered through Celite and rinsed with EtOAc.  
Then the organic solution was washed with sat. NaHCO3, dried over Na2SO4, and 
concentrated.  The residue was purified by silica gel chromatography (50% EtOAc in 
hexanes) to yield the title compound (80 mg, 0.37 mmol, 55%).  1H NMR (300 MHz, 
CDCl3) δ 8.42 (s, 0.2H, CHO), 8.27 (s, 0.8H, CHO), 7.46 (m, 1H, aryl), 7.3 (m, 3H, 
aryl), 5.63 (m, 1H, OCH), 4.86 (dt, 0.8H, J = 3.6, 2.1 Hz, NCH), 4.71 (m, 0.2H, NCH), 
3.43 (dd, 1H, J = 18, 7.8 Hz, benzylic), 3.20 (dd, 1H, J = 17.1, 3 Hz, benzylic), 1.65 (s, 
0.6H, CCH3), 1.60 (s, 2.4H, CCH3), 1.40 (s, 0.6H, CCH3), 1.29 (s, 2.4H, CCH3); 13C 
NMR (75 MHz, CDCl3) δ 158.8, 158.2, 141.7, 135.9, 129.6, 127.6, 127.3, 125.4, 125.3, 




1-aminoindanol formamide (24): (1S,2R)-1-amino-2-indanol (200 mg, 1.34 mmol) was 
dissolved in acetone (1 mL) and MgSO4 (160 mg).  After 2 hrs, the solution was filtered 
and concentrated. Meanwhile, acetyl chloride (110 µL, 1.54 mmol) and 98% formic acid 




was then added dropwise and stirred for 5 min.  A solution of the oxazolidine in EtOAc 
(2 mL) was added and the reaction was allowed to stir overnight.  The suspension was 
then filtered through Celite and rinsed with EtOAc.  Then the organic solution was 
washed with sat. NaHCO3, dried over Na2SO4, and concentrated.  The residue was 
purified by silica gel chromatography (50% EtOAc in hexanes) to yield the title 
compound (240 mg, 1.1 mmol, 82%).  1H NMR (300 MHz, CDCl3) δ 8.71 (s, 0.22H, 
CHO), 8.35 (s, 0.78H, CHO), 7.67-7.26 (m, 4H, aryl), 5.68 (d, 0.78H, J = 3.9 Hz, CHN), 
5.27 (m, 0.22H, CHN), 4.98 (m, 0.22H, OCH), 4.90 (m, 0.78H, OCH), 3.16 (m, 2H, 
benzylic), 1.63 (s, 0.6H, CH3), 1.56 (s, 2.4H, CH3), 1.37 (s, 0.6H, CH3), 1.33 (s, 2.4H, 
CH3); 13C NMR (75 MHz, CDCl3) δ 158.4, 158.1, 141.4, 140.4, 140.2, 140.0, 128.6, 
128.3, 127.3, 127.2, 126.6, 125.5, 124.8, 123.7, 95.0, 93.1, 78.7, 65.2, 63.5, 37.3, 36.8, 





1,2-diphenylethanol (300 mg, 1.41 mmol), MgSO4 (170 mg), and acetone (1.5 mL) were 
stirred for 3 hrs.  The reaction was filtered through Celite and concentrated. Meanwhile, 
acetyl chloride (115 µL, 1.62 mmol) and 98% formic acid (64 µL, 1.69 mmol) were 
cooled in EtOAc (4 mL) to –78 °C.  Et3N (491 µL, 3.52 mmol) was then added dropwise 






reaction was allowed to stir overnight.  The suspension was then filtered through Celite 
and rinsed with EtOAc.  Then the organic solution was washed with sat. NaHCO3, dried 
over Na2SO4, and concentrated.  The residue was purified by silica gel chromatography 
(50% EtOAc in hexanes) to yield the title compound (260 mg, 0.92 mmol, 66%).  1H 
NMR (300 MHz, CDCl3) δ 8.38 (s, 0.5H, CHO), 8.22 (s, 0.5H, CHO), 7.01 (m 10H, 
aryl), 5.58 (d, 0.5H, J = 6.3 Hz, NCH), 5.51 (d, 0.5H, J = 6.3 Hz, NCH), 5.35 (d, 0.5H, J 
= 6.3 Hz, OCH), 5.13 (d, 0.5H, J = 6.3 Hz, OCH), 2.03 (s, 1.5H, CH3), 1.94 (s, 1.5H, 
CH3), 1.77 (s, 1.5H, CH3), 1.22 (s, 1.5H, CH3); 13C NMR (75 MHz, CDCl3) δ 160.1, 
158.1, 137.9, 136.2, 135.1, 135.0, 127.9, 127.7, 127.6, 127.5, 126.7, 126.6, 93.9, 92.3, 





phenylalaninol8 (100 mg, 0.56 mmol) was dissolved in acetone (1 mL) and a small scoop 
of MgSO4.  After 3 hrs, the solution was filtered and concentrated. Meanwhile, acetyl 
chloride (46 µL, 0.64 mmol) and 98% formic acid (25 µL, 0.67 mmol) were cooled in 
EtOAc (2 mL) to –78 °C.  Et3N (195 µL, 1.4 mmol) was then added dropwise and stirred 
for 5 min.  A solution of the oxazolidine in EtOAc (1 mL) was added and the reaction 
was allowed to stir overnight.  The suspension was then filtered through Celite and rinsed 
                                                        








with EtOAc.  Then the organic solution was washed with sat. NaHCO3, dried over 
Na2SO4, and concentrated.  The residue was purified by silica gel chromatography (20% 
EtOAc in hexanes) to yield the title compound (100 mg, 0.4 mmol, 72%).  1H NMR (300 
MHz, CDCl3) δ 8.29 (s, 0.64H, CHO), 7.85 (s, 0.36H, CHO), 7.27 (m, 5H, aryl), 4.37 
(dd, 0.64H, J = 10.2, 3.9 Hz, CHN), 3.84 (dd, 036H, J = 6.3, 6.3 Hz, CHN), 3.42 (dd, 
0.64H, J = 12.6, 2.4 Hz, benzylic), 2.69 (m, 0.64H, benzylic), 2.80 (dd, 0.72H, J = 14.1, 
9.9 Hz, benzylic), 2.24-1.74 (m, 4H, CH2CH3), 1.34 (s, 1H, CH3), 1.29 (s, 2H, CH3), 1.26 
(s, 1H, CH3), 1.15 (s, 2H, CH3) 0.99 (t, 1.1H, J = 7.6 Hz, CH2CH3), 0.96 (t, 3.8H, J = 7.6 
Hz, CH2CH3), 0.87 (t, 1.1H, J = 7.6 Hz, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 158.9, 
158.6, 138.4, 136.8, 129.5, 129.1, 128.3, 127.0, 126.2, 93.0, 91.3, 81.3, 80.6, 66.9, 63.5, 




(R)-4-phenyl-2,2-dipropyloxazolidine-3-carbaldehyde (27): (R)-Phenylglycinol (200 
mg, 1.46 mmol), 4-heptanone (612 µL, 4.38 mmol), and MgSO4 (100 mg) was heated to 
90 °C overnight.  The reaction was filtered through Celite, rinsed with DCM, and 
concentrated.  Meanwhile, acetyl chloride (119 µL, 1.68 mmol) and 98% formic acid (66 
µL, 1.73 mmol) were cooled in EtOAc (3 mL) to –78 °C.  Et3N (509 µL, 3.65 mmol) was 
then added dropwise and stirred for 5 min.  A solution of the oxazolidine in EtOAc (1.5 






filtered through Celite and rinsed with EtOAc.  Then the organic solution was washed 
with sat. NaHCO3, dried over Na2SO4, and concentrated.  The residue was purified by 
silica gel chromatography (20% EtOAc in hexanes) to yield the title compound (142 mg, 
0.54 mmol, 37%).  1H NMR (300 MHz, CDCl3) δ 8.26 (s, 0.5H, CHO), 7.98 (s, 0,5H, 
CHO), 7.35 (m, 5H, aryl), 5.08 (dd, 0.5H, J = 6.9, 6.9 Hz, benzylic), 4.78 (dd, 0.5 H, J = 
9.0, 6.9 Hz, benzylic), 4.34 (m, 1H, OCH2), 3.95 (dd, 0.5H, J = 9.0, 6.3 Hz, OCH2), 3.87 
(dd, 0.5H, J = 9.0, 9.0 Hz, OCH2), 2.21-1.78 (m, 3H, CH2CH2CH3), 1.50 (m, 5H, 
CH2CH2CH3), 0.96 (m, 6H, CH2CH2CH3); 13C NMR (75 MHz, CDCl3) δ 159.8, 159.3, 
138.8, 137.0, 129.2, 128.7, 128.5, 127.5, 126.3, 99.2, 97.2, 72.2, 70.9, 62.3, 59.4, 41.2, 




(S)-4-benzyl-2,2-diethyloxazolidine-3-carbaldehyde (28): (S)-penylalaninol (500 mg, 
3.31 mmol) and 3-pentanone (1.5 mL, 14.2 mmol) were heated to 50 °C for 5 hrs.  The 
reaction was concentrated. Meanwhile, acetyl chloride (270 µL, 3.81 mmol) and 98% 
formic acid (150 µL, 3.97 mmol) were cooled in EtOAc (8 mL) to –78 °C.  Et3N (1.15 
mL, 8.27 mmol) was then added dropwise and stirred for 5 min.  A solution of the 
oxazolidine in EtOAc (4 mL) was added and the reaction was allowed to stir overnight.  
The suspension was then filtered through Celite and rinsed with EtOAc.  Then the 






The residue was purified by silica gel chromatography (50% EtOAc in hexanes) to yield 
the title compound (400 mg, 1.62 mmol, 49%).  1H NMR (300 MHz, CDCl3) δ 8.17 (s, 
0.78H, CHO), 8.10 (s, 0.22H, CHO), 7.26 (m, 5H), 4.32 (m, 0.78H, NCH), 4.08 (m, 
0.22H, NCH), 4.00 (dd, 0.22H, J = 9, 6.6 Hz, OCH2), 3.85 (m, 1.78H, OCH2), 3.66 (m, 
0.22H), 3.47 (dd, 0.78H, J = 13.2, 3.3 Hz, benzylic), 3.03 (dd, 0.22H, J = 13.5, 6.3 Hz, 
benzylic), 2.89 (dd, 0.22H, J = 13.2, 7.8 Hz, benzylic), 2.63 (dd, 0.78H, J = 13.2, 10.5 
Hz, benzylic), 2.10 (m, 0.22H, CH2CH3), 2.00 (m, 0.22H, CH2CH3), 1.77 (m, 3H, 
CH2CH3), 0.91 (m, 6H, CH2CH3). 
 
 
(S)-3-benzyl-1-oxa-4-azaspiro[4.5]decane-4-carbaldehyde (29): (S)-Phenylalaninol 
(200 mg, 1.32 mmol) and cyclohexanone (138 µL, 1.32 mmol) were dissolved in benzene 
(1 mL) and heated to 70 °C for 2.5 hrs.  The reaction was then concentrated and used 
without further purification. Meanwhile, acetyl chloride (108 µL, 1.52 mmol) and 98% 
formic acid (60 µL, 1.58 mmol) were cooled in EtOAc (3 mL) to –78 °C.  Et3N (460 µL, 
3.3 mmol) was then added dropwise and stirred for 5 min.  A solution of the oxazolidine 
in EtOAc (1.5 mL) was added and the reaction was allowed to stir overnight.  The 
suspension was then filtered through Celite and rinsed with EtOAc.  Then the organic 
solution was washed with sat. NaHCO3, dried over Na2SO4, and concentrated.  The 
residue was purified by silica gel chromatography (35% EtOAc in hexanes) to yield the 





0.77H, CHO), 7.85 (s, 0.23H, CHO), 7.27 (m, 5H, aryl), 4.34 (m, 0.77H, CHN), 3.78 (m, 
2.23H, CHN, OCH2), 3.31 (dd, 0.77H, J = 13.2, 3.3 Hz, benzylic), 2.90 (d, 0.46H, J = 6.9 
Hz, benzylic), 2.64 (dd, 0.77H, J = 13.2, 10.5 Hz, benzylic), 2.60 (m, 0.23H, cyclohexyl), 
2.40 (m, 0.23H, cyclohexyl), 1.90-1.10 (m, 9.54H, cyclohexyl); 13C NMR (75 MHz, 
CDCl3) δ 158.9, 158.1, 137.8, 136.8, 129.4, 128.8, 128.5, 127.0, 126.5, 95.7, 93.6, 67.3, 




(S)-3-benzyl-1-oxa-4-azaspiro[4.4]nonane-4-carbaldehyde (30): : (S)-Phenylalaninol 
(200 mg, 1.32 mmol) and cyclopentanone (117 µL, 1.32 mmol) were dissolved in 
benzene (1 mL) and heated to 70 °C for 5 hrs.  The reaction was then concentrated and 
used without further purification. Meanwhile, acetyl chloride (108 µL, 1.52 mmol) and 
98% formic acid (60 µL, 1.58 mmol) were cooled in EtOAc (3 mL) to –78 °C.  Et3N (460 
µL, 3.3 mmol) was then added dropwise and stirred for 5 min.  A solution of the 
oxazolidine in EtOAc (1.5 mL) was added and the reaction was allowed to stir overnight.  
The suspension was then filtered through Celite and rinsed with EtOAc.  Then the 
organic solution was washed with sat. NaHCO3, dried over Na2SO4, and concentrated.  
The residue was purified by silica gel chromatography (35% EtOAc in hexanes) to yield 
the title compound (120 mg, 0.49 mmol, 37%).  1H NMR (300 MHz, CDCl3) δ 8.32 (s, 





0.4H, CHN), 3.85 (d, 1H, J = 3 Hz, OCH2), 3.81 (d, 0.4H, J = 2.4 Hz, OCH2), 3.73 (dd, 
0.6H, J = 9.3, 6.0 Hz, OCH2), 3.27 (dd, 0.6H, J = 12.9, 3.0 Hz, benzylic), 2.90 (d, 0.8H, J 
= 7.2 Hz, benzylic), 2.69 (dd, 0.6H, J = 12.9, 9.9 Hz, benzylic), 2.52 (m, 0.4H, 
cyclopentyl), 2.28 (m, 0.4H, cyclopentyl), 1.80 (m, 7.2H, cyclopentyl); 13C NMR (75 
MHz, CDCl3) δ 158.6, 157.9, 137.5, 136.7, 129.5, 129.4, 128.8, 128.4, 127.0, 126.5, 





1,2-diphenylethanol (200 mg, 0.94 mmol) and 3-pentanone (400 µL, 3.75 mmol) in 
benzene (1 mL) were heated to 50 °C for 3 hrs.  The reaction was concentrated. 
Meanwhile, acetyl chloride (77 µL, 1.08 mmol) and 98% formic acid (43 µL, 1.13 mmol) 
were cooled in EtOAc (2 mL) to –78 °C.  Et3N (328 µL, 2.38 mmol) was then added 
dropwise and stirred for 5 min.  A solution of the oxazolidine in EtOAc (1 mL) was 
added and the reaction was allowed to stir overnight.  The suspension was then filtered 
through Celite and rinsed with EtOAc.  Then the organic solution was washed with sat. 
NaHCO3, dried over Na2SO4, and concentrated.  The residue was purified by silica gel 
chromatography (50% EtOAc in hexanes) to yield the title compound (140 mg, 0.45 
mmol, 48%).  1H NMR (300 MHz, CDCl3) δ 8.37 (s, 0.7H, CHO), 8.21 (s, 0.3H, CHO), 






5.45 (d, 0.7H, J = 6.9 Hz, OCH), 5.25 (d, 0.3H, J = 7.8 Hz, OCH), 2.45 (m, 0.7H, 
CH2CH3), 2.22 (m, 2H, CH2CH3), 2.07 (m, 2.3H, CH2CH3), 1.23 (m, 3H, CH2CH3), 1.08 
(m, 3H, CH2CH3); 13C NMR (75 MHz, CDCl3) δ 160.7, 158.9, 137.9, 136.3, 135.8, 
128.1, 127.8, 127.6, 127.5, 127.4, 126.9, 126.7, 98.9, 96.9, 80.1, 80.0, 65.1, 63.1, 31.0, 




(S)-2,2-diethyl-4-methyloxazolidine-3-carbaldehyde (32): (S)-alaninol (300 µL, 3.85 
mmol) and 3-pentanone (1.63 mL, 15.4 mmol) were heated to 50 °C for 3 hrs.  The 
reaction was concentrated at 200 torr with a water bath at 85 °C and then at 30 torr with 
the bath at 20 °C briefly to remove excess ketone.  The crude material was used as is. 
Meanwhile, acetyl chloride (314 µL, 4.43 mmol) and 98% formic acid (174 µL, 4.62 
mmol) were cooled in EtOAc (8 mL) to –78 °C.  Et3N (1.34 mL, 9.6 mmol) was then 
added dropwise and stirred for 5 min.  A solution of the oxazolidine in EtOAc (4 mL) 
was added and the reaction was allowed to stir overnight.  The suspension was then 
filtered through Celite and rinsed with EtOAc.  Then the organic solution was washed 
with sat. NaHCO3, dried over Na2SO4, and concentrated.  The residue was purified by 
silica gel chromatography (75% Et2O in pentane) to yield the title compound (330 mg, 
2.31 mmol, 60%).  1H NMR (300 MHz, CDCl3) δ 8.32 (s, 0.3H, CHO), 8.11 (s, 0.7H, 






(dd, 0.7H, J = 8.7, 3.9 Hz, OCH2), 3.61 (dd, 0.3H, J = 8.7, 3 Hz, OCH2), 2.1-1.7 (m, 4H, 





Adamantanone derived formamide (33): (S)-Phenylalaninol (200 mg, 1.32 mmol) and 
2-adamantanone (198 mg, 1.32 mmol) were dissolved in benzene (1 mL) and heated to 
50 °C overnight.  The reaction was then concentrated and used without further 
purification. Meanwhile, acetyl chloride (108 µL, 1.52 mmol) and 98% formic acid (60 
µL, 1.58 mmol) were cooled in EtOAc (3 mL) to –78 °C.  Et3N (460 µL, 3.3 mmol) was 
then added dropwise and stirred for 5 min.  A solution of the oxazolidine in EtOAc (1.5 
mL) was added and the reaction was allowed to stir overnight.  The suspension was then 
filtered through Celite and rinsed with EtOAc.  Then the organic solution was washed 
with sat. NaHCO3, dried over Na2SO4, and concentrated.  The residue was purified by 
silica gel chromatography (20% EtOAc in hexanes) to yield the title compound (150 mg, 
0.48 mmol, 37%).  1H NMR (300 MHz, CDCl3) δ 8.92 (s, 1H, CHO), 7.29 (m, 5H, aryl), 
4.52 (dddd, 1H, J = 10.4, 5.7, 5.7, 5.7 Hz, NCH), 3.84 (dd, 1H, J = 7.8, 7.2 Hz, OCH2), 
3.75 (dd, 1H, J = 9.0, 5.4 Hz, OCH2), 3.34 (dd, 1H, J = 13.2, 3.6 Hz, benzylic), 2.66 (dd, 





CDCl3) δ 160.4, 137.8, 129.3, 128.4, 126.5, 97.5, 64.9, 57.4, 39.2, 38.9, 38.1, 36.2, 35.9, 




(R)-2,2,4-triphenyloxazolidine-3-carbaldehyde (34): (R)-Phenylglycinol (500 mg, 3.64 
mmol), benzophenone (664 mg, 3.64 mmol), p-toluenesulfonic acid (35 mg, 0.18 mmol), 
and toluene (30 mL) were heated for 2 days with a dean-stark trap.  An additional 0.1 eq 
of benzophenone was added and heated for an additional 24 hrs.  At this point the 
reaction was concentrated to yield the crude oxazolidine, which existed in an qwuilibrium 
mixture of oxazolidine and imino-alcohol. Meanwhile, acetyl chloride (298 µL, 4.19 
mmol) and 98% formic acid (165 µL, 4.37 mmol) were cooled in EtOAc (8 mL) to –78 
°C.  Et3N (1.27 mµL, 9.1 mmol) was then added dropwise and stirred for 5 min.  A 
solution of the oxazolidine in EtOAc (4 mL) was added and the reaction was allowed to 
stir overnight.  The suspension was then filtered through Celite and rinsed with EtOAc.  
Then the organic solution was washed with sat. NaHCO3, dried over Na2SO4, and 
concentrated.  The residue was purified by silica gel chromatography (5 to 20% Et2O in 
hexanes) to yield the title compound (200 mg, 0.61 mmol, 17%).  1H NMR (300 MHz, 
CDCl3) δ 8.01 (s, 1H, CHO), 7.69 (dd, 2H, J = 6.0, 3.0 Hz, aryl), 7.4-7.28 (m, 11H, aryl), 
7.07 (dd, 2H, J = 6.0, 3.0 Hz, aryl), 4.7 (dd, 1H, J = 9.0, 3.0 Hz, benzylic), 4.54 (dd, 1H, 






δ 169.1, 160.6, 140.3, 139.5, 136.5, 130.2, 128.6, 128.5, 128.3, 128.0, 127.7, 127.5, 





glycinol (200 mg, 1.46 mmol), pinacolone (548 µL, 4.38 mmol), and MgSO4 (100 mg) 
was heated to 90 °C overnight.  The reaction was filtered through Celite, rinsed with 
DCM, and concentrated.  Meanwhile, acetyl chloride (119 µL, 1.68 mmol) and 98% 
formic acid (66 µL, 1.73 mmol) were cooled in EtOAc (3 mL) to –78 °C.  Et3N (509 µL, 
3.65 mmol) was then added dropwise and stirred for 5 min.  A solution of the oxazolidine 
in EtOAc (1.5 mL) was added and the reaction was allowed to stir overnight.  The 
suspension was then filtered through Celite and rinsed with EtOAc.  Then the organic 
solution was washed with sat. NaHCO3, dried over Na2SO4, and concentrated.  The 
residue was purified by silica gel chromatography (35% EtOAc in hexanes) to yield the 
title compound (40 mg, 0.16 mmol, 11%).  1H NMR (300 MHz, CDCl3) δ 8.46 (s, 1H, 
CHO), 7.41 (m, 5H, aryl), 5.41 (dd, 1H, J = 6.9, 2.7 Hz, benzylic), 4.38 (dd, 1H, J = 9.3, 
3.3 Hz, OCH2), 4.27 (dd, 1H, J = 9.0, 7.5 Hz, OCH2), 1.57 (s, 3H, CCH3), 0.95 (s, 9H, 
tert-butyl); 13C NMR (75 MHz, CDCl3) δ 162.4, 138.7, 128.2, 127.4, 100.5, 68.5, 58.2, 











(2S,5S)-2,5-dibenzylpyrrolidine-1-carbaldehyde (41): (2S,5S)-2,5-dibenzylpyrrolidine9 
(180 mg, 0.66 mmol) was heated with ethyl formate (1 mL) in a sealed vial to 57 °C for 
36 hrs.  The solution was concentrated and purified by silica gel chromatography (30 % 
EtOAc in hexanes) to yield the formamide (150 mg, 0.54 mmol, 81%).  1H NMR (300 
MHz, CDCl3) δ 8.17 (s, 1H, CHO), 7.29-7.11 (m, 10H, aryl), 4.29 (m, 1H, NCH), 3.96 
(dd, 1H, J = 13.8, 6.3 Hz, NCH), 3.27 (dd, 1H, J = 13.2, 3.3 Hz, benzylic), 2.85 (dd, 1H, 
J = 13.5, 6 Hz, benzylic), 2.71 (dd, 1H, J = 13.5, 7.8 Hz, benzylic), 2.59 (dd, 1H, J = 
13.2, 9.3 Hz, benzylic), 1.71 (m, 4H, CH2CH2); 13C NMR (75 MHz, CDCl3) δ 160.8, 





(2S,5S)-dimethyl 1-formylpyrrolidine-2,5-dicarboxylate (42): Acetyl chloride (28 µL, 
0.39 mmol) and 98% formic acid (15 µL, 0.41 mmol) were cooled in EtOAc (800 µL) to 
–78 °C.  Et3N (118 µL, 0.85 mmol) was then added dropwise and stirred for 5 min.  A                                                         








solution of (2S,5S)-dimethyl pyrrolidine-2,5-dicarboxylate10 in EtOAc (400 µL) was 
added and the reaction was allowed to stir overnight.  The suspension was then filtered 
through Celite and rinsed with EtOAc.  Then the organic solution was washed with sat. 
NaHCO3, 1 N HCl, dried over Na2SO4, and concentrated.  Pure product was obtained (62 
mg, 0.29 mmol, 85%). 1H NMR (300 MHz, CDCl3) δ 8.30 (s, 1H, CHO), 4.60 (t, 2H, J = 
7.8 Hz, NCHCO2Me), 3.78 (s, 3H, CO2CH3), 3.75 (s, 3H, CO2CH3), 2.38 (m, 1H, 
CH2CH2), 2.28 (m, 2H, CH2CH2), 2.04, (m, 1H, CH2CH2); 13C NMR (75 MHz, CDCl3) δ 






tert-butylphenyl)pyrrolidine (50 mg, 0.15 mmol) was heated with ethyl formate (1 mL) in 
a sealed vial to 57 °C for 36 hrs.  The solution was concentrated and purified by silicagel 
chromatography (15% EtOAc in hexanes) to yield pure product (40 mg, 0.11 mmol, 
73%). 1H NMR (300 MHz, CDCl3) δ 8.17 (s, 1H, CHO), 7.37 (m, 4H, aryl), 7.18 (m, 4H, 
aryl), 5.36 (m, 1H, benzylic), 5.12 (m, 1H, benzylic), 2.45 (m, 2H, CH2CH2), 1.88 (m, 
2H, CH2CH2), 1.32 (s, 9H, C(CH3)3), 1.30 (s, 9H, C(CH3)3); 13C NMR (75 MHz, CDCl3) 
                                                        






δ 161.9, 150.8, 149.6, 139.4, 138.8, 126.2, 125.8, 125.4, 125.1, 62.0, 59.7, 34.5, 34.3, 




(2R,5R)-2,5-bis(4-bromophenyl)pyrrolidine (58): Methanesulfonyl chloride (1.97 mL, 
25.5 mmol) was added slowly to a mixture of (1S,4S)-1,4-bis(4-bromophenyl)butane-1,4-
diol11 (3.4 g, 8.5 mmol) and Et3N (3.55 mL, 25.5 mmol) in DCM (167 mL) at –20 °C.  
After 2 hrs, the reaction was quenched with sat. NH4Cl and then diluted with EtOAc (300 
mL).  The organic layer was washed with water, dried over Na2SO4, and concentrated.  
The crude bismesylate was cooled to 0 °C and allylamine (60 mL) was introduced.  After 
stirring overnight at 23 °C, the reaction was concentrated and the residue purified via 
silica gel chromatography (3% Et2O in hexanes) to yield the pyrrolidine (1.5 g, 3.56 
mmol, 42%). %). 1H NMR (300 MHz, CDCl3) δ 7.45 (d, 4H, J = 8.4 Hz, aryl), 7.17 (d, 
4H, J = 8.4 Hz, aryl), 5.59 (m, 1H, CHCH2), 4.93 (m, 2H, CHCH2), 4.26 (m, 2H, 
benzylic), 2.94 (ddd, 1H, J = 12.9, 4.5, 2.4 Hz, allylic), 2.68 (dd, 1H, J = 15, 7.5 Hz, 
allylic), 2.49 (m, 2H, CH2CH2), 1.84 (m, 2H, CH2CH2). 
RhCl(PPh3)3 was added to a mixture of N-allyl pyrrolidine (1.5 g, 3.56 mmol) in MeCN 
(75 mL) and water (13 mL).  The solution was heated to reflux with a distillation 
apparatus attached.  Additional solvent was added to keep the total volume relatively 
constant.  After refluxing for 2.5 hrs, approximately 80 mL was collected.  Et2O (400                                                         





mL) was added and the organic layer was washed with brine, dried over MgSO4, and 
concentrated.  The residue was purified by silica gel chromatography to furnish the 
pyrrolidine (1.0 g, 2.58 mmol, 72%). 1H NMR (300 MHz, CDCl3) δ 7.45 (d, 4H, J = 8.7 
Hz, aryl), 7.28 (d, 4H, J = 9.0 Hz, aryl), 4.48 (dd, 2H, J = 6.3, 6.3 Hz, benzylic), 2.38 (m, 
2H, CH2CH2), 1.98 (bs, 1H, NH), 1.83 (m, 2H, CH2CH2); 13C NMR (75 MHz, CDCl3) δ 




(2R,5R)-2,5-bis(4-bromophenyl)pyrrolidine-1-carbaldehyde (44): The pyrrolidine 44 
(150 mg, 0.4 mmol) was dissolved in ethyl formate (1 mL) and heated to 57 °C in a 
sealed vial for 24 hrs.  The reaction was then concentrated to afford pure formamide (160 
mg, 0.4 mmol, quantitative). 1H NMR (300 MHz, CDCl3) δ 8.17 (s, 1H, CHO), 7.52 (d, 
2H, J = 8.4 Hz, aryl), 7.47 (d, 2H, J = 8.4 Hz, aryl), 7.14 (d, 2H, J = 8.7 Hz, aryl), 7.11 
(d, 2H, J = 8.7 Hz, aryl), 5.32 (dd, 1H, J = 7.5, 2.4 Hz, benzylic), 5.14 (dd, 1H, J = 6.3, 
2.7 Hz, benzylic), 2.44 (m, 2H, CH2CH2), 1.86 (m, 2H, CH2CH2); 13C NMR (75 MHz, 














Benzaldehyde (195 µL,  1.93 mmol) was added to a solution of (–)-Menthylamine12 (349 
µL, 1.93 mmol) in methanol (2 mL).  After 2 hrs, NaBH4 (149 mg, 3.93 mmol) was 
added slowly, stirred for 20 min, and then quenched with the addition of water.  The 
reaction was concentrated, extracted into EtOAc, dried over Na2SO4, and concentrated.  
The residue was purified via silica gel chromatography (35% EtOAc in hexanes) to yield 
the benzylamine (250 mg, 1.02 mmol, 53%). 
The above amine was mixed with ethyl formate (1.5 mL) and heated for 36 hrs at 57 °C.  
The solution was concentrated to reveal pure formamide (278 mg, 1.02 mmol, 
quantitative). 1H NMR (300 MHz, CDCl3) δ 8.29 (s, 1H, CHO), 7.31 (m, 5H, aryl), 4.56 
(m, 1H), 4.36 (m, 1H), 4.25 (m, 1H), 1.68 (m, 4H), 1.41-0.9 (m, 5H), 0.9-0.6 (m, 9H); 
13C NMR (75 MHz, CDCl3) δ 163.7, 162.0, 137.8, 128.5, 128.1, 128.0, 127.4, 127.0, 
59.8, 52.7, 47.2, 43.9, 41.6, 39.8, 34.1, 34.0, 32.4, 32.2, 26.1, 25.3, 23.5, 21.8, 21.0, 20.8, 














(S)-2,2-diethyl-5-(methoxymethyl)pyrrolidine-1-carbaldehyde (46): Following a 
modified precedure,13 to a cooled (–78 °C) solution of (S)-1-benzyl-5-
(methoxymethyl)pyrrolidin-2-one14 (400 mg, 1.82 mmol) and 2,6-di-tert-butyl-4-
methylpyridine (449 mg, 2.19 mmol) in DCM (10 mL) was added 
trifluoromethanesulfonic anhydride (368 µL, 2.19 mmol) dropwise and the solution was 
stirred for 45 min.  Then EtMgBr (1.82 mL, 5.46 mmol, 3M in Et2O) was added and the 
reaction was allowed to warm to 23 °C and stir for 3 hrs.  The solution was quenched 
with sat. NH4Cl, extracted with DCM, dried over Na2SO4, filtered, and concentrated.  The 
residue was purified via silica gel chromatography to yield the N-benzylpyrrolidine (170 
mg, 0.65 mmol, 36%).  The N-benzylpyrrolidine was then dissolved in EtOAc (6 mL), 
20% Pd(OH)2/C (79 mg) was added, and the heterogeneous mixture was stirred for 24 hrs 
under H2 (1 atm).  The reaction was then filtered through Celite, rinsed with EtOAc, and 
then concentrated.  The residue was then dissolved in ethyl formate (1 mL) and heated to 
57 °C for 24 hrs.  After concentrating the reaction, the residue was purified by silica gel 
chromatography to yield the formamide (62 mg, 0.31 mmol, 48%). 1H NMR (300 MHz, 
CDCl3) δ 8.36 (s, 0.2H, CHO), 8.34 (s, 0.8H, CHO), 4.26 (m, 0.8H, CHN), 3.94 (m, 
0.2H, CHN), 3.62 (dd, 0.8H, J = 9.3, 3.6 Hz, CH2OCH3), 3.42 (m, 4.2H, CH2OCH3), 2.1-
1.8 (m, 3H, alkyl), 1.75-1.58 (m, 4H, alkyl), 0.9 (m, 6H, CH2CH3); 13C NMR (75 MHz,                                                         
13 Xiao, K.-J.; Luo, J.-M.; Ye, K.-Y.; Wang, Y.; Huan, P.-Q. Angew. Chem. Int. Ed. 2010, 
49, 3037-3040. 








CDCl3) δ 161.7, 161.0, 75.6, 71.9, 68.6, 66.5, 58.8, 56.8, 33.4, 32.5, 32.1, 31.8, 29.6, 





)pyrrolidine (70 mg, 0.18 mmol), Pd(PPh3)4 (41 mg, 0.036 mmol), and Zn(CN)2 (42 mg, 
0.36 mmol) were placed in a 2 dram vial under argon.  DMF (1.1 mL) was added and the 
suspension was heated to 80 °C for 18 hrs.  Upon cooling to 23 °C, water was added and 
the solution was extracted with Et2O.  The organics were combined, dried over MgSO4, 
and concentrated.  Purification by silica gel chromatography afforded the pyrrolidine as a 
off-white solid (40 mg, 0.15 mmol, 83%).  1H NMR (300 MHz, CDCl3) δ 7.64 (d, 4H, J 
= 8.4 Hz, aryl), 7.51 (d, 4H, J = 8.4 Hz, aryl), 4.60 (dd, 2H, J = 6.6, 6.6 Hz, benzylic), 





pyrrolidine-2,5-diyl)dibenzonitrile (40 mg, 0.15 mmol) was dissolved in ethyl formate (1 
mL) and heated to 57 °C in a sealed vial for 18 hrs.  The reaction was then concentrated 








(s, 1H, CHO), 7.71 (d, 2H, J = 8.4 Hz, aryl), 7.65 (d, 2H, J = 8.4 Hz, aryl), 7.40 (d, 2H, J 
= 8.4 Hz, aryl), 7.35 (d, 2H, J = 8.4 Hz, aryl), 5.42 (m, 1H, benzylic), 5.29 (m, 1H, 
benzylic), 2.450 (m, 2H, CH2CH2), 1.91 (m, 2H, CH2CH2); 13C NMR (75 MHz, CDCl3) 
δ 161.3, 147.4, 146.8, 132.9, 132.5, 126.9, 126.3, 118.6, 118.1, 112.1, 111.1, 61.8, 60.1, 
32.9, 31.5. 
 
General chlorination procedure with chiral formamide: Methyl mandelate (33 mg, 
0.2 mmol) and formamide (0.02 mmol) were placed in a vial under argon and diluted 
with CDCl3 (1 mL).  Oxalyl chloride (8.6 µL, 0.1 mmol) was added and the reaction was 
monitored by 1H NMR spectroscopy.  Typically reactions were finished within two 
hours.  Upon completion, the solution was concentrated and purified by silica gel 





Enantiomeric excess of methyl α–chlorophenylacetate was determined using a DIACEL 
OD column using the following conditions: 
A: i-PrOH: hexanes 2:98, 1 mL/min, λ = 210 nm, R enant. 8.3 min, S enant. 9.7 min. 
B: i-PrOH: hexanes 2:98, 1 mL/min, λ = 254 nm, R enant. 8.3 min, S enant. 9.7 min. 
C: i-PrOH: hexanes 2.5:97.5, 1 mL/min, λ = 254 nm, R enant. 6.1 min, S enant. 6.7 min. 
 
































































































































Table 1: Temperature Screen 
 
















40 °C, Method C 
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